Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

C3_BREAST_ERPLUS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions RX_ERPLUS	15625
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C50 Hospital discharge: ICD-9 — 174 Hospital discharge: ICD-8 — 174 Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 3 out of 7 registries used, show all original rules.	14939
4. Check minimum number of events None	14939
5. Include endpoints None	14939
6. Filter based on genotype QC (FinnGen only)	14939

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC
Control conditions: not RX_ERPLUS

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BREAST_ERPLUS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C50
HD_ICD_9	174
HD_ICD_8	174
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of breast, HER-positive

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14939	14939	-
Unadjusted period prevalence (%)	5.09	5.09	-
Median age at first event (years)	60.08	60.08	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12433: Matched controls
105123

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

6736.8

323.0

758

ZX112

NOMESCO Finland

Subcutaneous

23.2

323.0

658

252

394

Kela drug reimbursment

Palbociclib

+∞

323.0

488

HA1AA

NOMESCO Finland

X-ray mammography

55.1

323.0

6540

2076

NK6AN

NOMESCO Finland

Total body bone isotope imaging

179.4

323.0

1429

X76

ICPC

Malignant neoplasm breast female

3626.1

323.0

1879

XX1XN

NOMESCO Finland

Other isotope examination

2348.1

323.0

549

1501

Kela drug reimbursment

Palbociclib

+∞

323.0

549

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

131.1

323.0

675

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

114.5

323.0

739

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

3451.8

323.0

1803

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

99.2

323.0

2460

261

192

Kela drug reimbursment

Fulvestrant

+∞

323.0

529

R4110

NOMESCO Finland

Physiotherapy

2.9

323.0

4424

16800

L03AA13

ATC

pegfilgrastim; parenteral

9150.1

323.0

2608

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

323.0

723

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

41.2

323.0

718

156

115

Kela drug reimbursment

Breast cancer

+∞

323.0

12341

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

359

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

492.5

323.0

396

WX404

NOMESCO Finland

Intravenous generell anesthesy

5.4

323.0

5102

11996

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

12.2

323.0

1075

807

TQW20

NOMESCO Finland

Tatoe

308.5

323.0

952

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

11.8

323.0

3185

2992

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

7.5

323.0

1440

1792

ZZR10

NOMESCO Finland

Flap of skin and muscle

138.8

323.0

489

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

7.8

323.0

9268

28802

A03FA01

ATC

metoclopramide; systemic, rectal

14.2

323.0

7160

9173

L02BA01

ATC

tamoxifen; oral

6653.9

323.0

6075

M05BX04

ATC

denosumab; parenteral

5.1

323.0

1393

2561

HAB40

NOMESCO Finland

Wedge excision of mammary gland

244.5

323.0

4782

268

C50.99

ICD-10 Finland

Breast, unspecified

6372.6

323.0

2470

Z31.5

ICD-10 Finland

Genetic counselling

8.3

323.0

1424

1606

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

323.0

681

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

323.0

1491

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

383

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

2887.9

323.0

341

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

10196.5

323.0

2837

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

5.1

323.0

6471

18301

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

323.0

496

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

323.0

348

A79

ICPC

Malignancy NOS

229.1

323.0

393

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

5125.6

323.0

587

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

323.0

340

A04AA01

ATC

ondansetron; systemic, rectal

12.6

323.0

1612

1229

B01AB05

ATC

enoxaparin; parenteral

2.3

323.0

4325

19919

L01BC06

ATC

capecitabine; oral

+∞

323.0

756

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

803

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

323.0

509

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

323.0

1362

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

22.9

323.0

861

340

PJW99

NOMESCO Finland

Other operation on lymphatic system

1756.9

323.0

419

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

323.0

466

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

12497.1

323.0

1331

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

539.3

323.0

666

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

323.0

364

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3797.7

323.0

2585

JN4AD

NOMESCO Finland

Body CT examination

8.4

323.0

1081

1183

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4503599627370496.0

323.0

3809

PJA12

NOMESCO Finland

Sentinel node biopsy

8579.0

323.0

7790

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

73.3

323.0

1971

269

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

323.0

376

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4503599627370496.0

323.0

6475

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

820.4

323.0

1682

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1258.4

323.0

3450

ZX090

NOMESCO Finland

Other technic of radiotherapy

1368.1

323.0

1293

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

4767

HAE99

NOMESCO Finland

Other reconstruction of breast

80.4

323.0

528

L02BA03

ATC

fulvestrant; parenteral

+∞

323.0

560

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

323.0

395

L03AA14

ATC

lipegfilgrastim; parenteral

9359.1

323.0

1026

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

323.0

728

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

75.6

323.0

398

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

323.0

1179

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

274.2

323.0

435

Z51.0

ICD-10 Finland

Radiotherapy session

841.3

323.0

479

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

323.0

1377

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

58.3

323.0

491

WF003

NOMESCO Finland

Adjuvant radiotherapy

1245.3

323.0

1661

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

435.8

323.0

1258

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

8883.6

323.0

4264

XX3DW

NOMESCO Finland

Time consuming IT work

16.7

323.0

3220

2152

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

227.5

323.0

1991

HAB99

NOMESCO Finland

Other partial excision of mammary gland

36.9

323.0

1643

432

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

375.4

323.0

347

HAC20

NOMESCO Finland

Total mastectomy

2992.0

323.0

4588

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

7802.3

323.0

3908

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

237.5

323.0

838

L02BG04

ATC

letrozole; oral

1399.5

323.0

8193

139

H02AB02

ATC

dexamethasone; systemic

192.3

323.0

5936

497

A04AA55

ATC

palonosetron, combinations; systemic

16384.0

323.0

2224

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

85.4

323.0

1303

144

L02BG06

ATC

exemestane; oral

+∞

323.0

1797

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

517.1

323.0

415

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

323.0

1392

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

323.0

606

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

323.0

2069

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

323.0

467

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

16384.0

323.0

1699

A04AD12

ATC

aprepitant; systemic

2196.0

323.0

1441

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

323.0

1976

L02BG03

ATC

anastrozole; oral

3396.4

323.0

2080

D70.82

ICD-10 Finland

Drug-induced neutropenia

48.1

323.0

597

110

JN4BD

NOMESCO Finland

Extensive body CT

13.6

323.0

2503

1908

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

54.9

323.0

1585

279

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

323.0

3358

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

323.0

1865

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

21.4

323.0

531

219

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

1812.6

323.0

1113

1CD02

NOMESCO Finland

+∞

323.0

695

ZX080

NOMESCO Finland

Image guided radiotherapy

3448.9

323.0

1142

TQB05

NOMESCO Finland

Puncture of skin of trunk

52.0

323.0

474

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1582.1

323.0

380

C50

ICD-10 Finland

Malignant neoplasm of breast

3410.4

323.0

2087

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

323.0

351

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

232.5

323.0

822

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

54.8

323.0

480

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

323.0

876

L03AA02

ATC

filgrastim; parenteral

216.5

323.0

701

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

5811.3

323.0

1257

L01XE33

ATC

[U] palbociclib; oral

+∞

323.0

399

WF049

NOMESCO Finland

Radiotherapy of metastasis

1851.9

323.0

650

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1706.4

323.0

603

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

72.2

323.0

531

WZC30

NOMESCO Finland

Teaching

4.9

323.0

2411

4952

WX402

NOMESCO Finland

General anaesthesia

3.2

323.0

2489

7582

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

323.0

5531

25701

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

807.7

323.0

1131

ZZF00

NOMESCO Finland

Graft of adipose tissue

45.2

323.0

503

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

53.8

323.0

5678

1618

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

332.9

323.0

850

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

323.0

442

ZX120

NOMESCO Finland

Intravenous

6.3

323.0

2106

3280

N63

ICD-10 Finland

Unspecified lump in breast

5.6

323.0

1865

3216

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

323.0

575

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

160.2

323.0

368

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

323.0

1507

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

323.0

356

A04AA02

ATC

granisetron; systemic, transdermal

1041.4

323.0

3343

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

56.7

323.0

478

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

323.0

462

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

320.7

327

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

316.8

323

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

51.5

313.9

401

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

1451.3

313.1

324

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

933.6

310.1

323

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

309.9

316

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

306.9

313

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

305.9

312

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

304.9

3594

15612

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

2603.6

300.5

309

ZX070

NOMESCO Finland

Intensity modified radiotherapy

278.9

299.6

324

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

70.5

299.0

364

Z51.5

ICD-10 Finland

Palliative care

9.9

298.0

647

579

ZXA05

NOMESCO Finland

Left side

2.2

297.8

3907

17829

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

297.0

303

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

39.2

294.6

396

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

7.0

293.5

793

1015

WX702

NOMESCO Finland

Supraglottic ventilation device

4.5

290.7

1145

2307

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

443.4

290.1

308

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

290.1

296

L01CA04

ATC

vinorelbine; systemic

+∞

288.2

294

ZXA00

NOMESCO Finland

Right side

2.2

286.0

4091

19341

L01EF01

ATC

palbociclib; oral

+∞

285.2

291

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

284.4

5400

28767

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2435.5

281.8

290

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

241.2

279.7

305

HAC25

NOMESCO Finland

Radical mastectomy

+∞

272.4

278

JN4CD

NOMESCO Finland

Very extensive body CT

9.7

271.9

598

547

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

154.9

271.0

304

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

410.8

268.7

286

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

266.5

272

N02BE01

ATC

paracetamol; systemic, rectal

2.6

262.4

11237

82047

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

261.0

1396

3681

1XC03

NOMESCO Finland

1169.1

259.1

269

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

586.5

258.3

272

HA1HA

NOMESCO Finland

Tomosynthesis mammography

48.0

256.8

332

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

5.0

252.0

901

1632

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

251.8

257

WF002

NOMESCO Finland

Radical radiotherapy

39.4

250.3

336

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

182.1

247.1

274

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

246.8

252

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

169.1

245.8

274

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

373.9

244.3

261

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

440.4

241.0

256

HA1BA

NOMESCO Finland

Extensive X-ray mammography

24.9

236.6

355

124

WF004

NOMESCO Finland

Palliative radiotherapy

429.8

235.2

250

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

234.1

239

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

75.7

232.2

280

HAD99

NOMESCO Finland

Other plastic operation on breast

34.4

221.5

306

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

12.9

216.7

411

277

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

215.4

220

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1812.3

212.1

219

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

211.5

216

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

23.8

210.1

319

116

HA1SA

NOMESCO Finland

Expansion mammography

67.0

208.9

256

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

206.5

211

HAD40

NOMESCO Finland

Mastopexy

33.6

204.5

284

X21

ICPC

Breast sympt/compl female other

6.5

198.8

562

760

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

196.7

201

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

196.4

5132

29397

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

40.2

195.4

261

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

191.8

196

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

54.4

189.8

240

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

218.3

185.1

203

XX1AD

NOMESCO Finland

Other CT-examination

246.7

183.6

200

L02AE03

ATC

goserelin; implant

11.0

182.8

374

296

B01AB10

ATC

tinzaparin; parenteral

3.7

182.5

894

2169

R50.9

ICD-10 Finland

Fever, unspecified

2.5

181.0

1589

5731

L02AE02

ATC

leuprorelin; implant, parenteral

9.9

180.3

390

344

N02AA05

ATC

oxycodone; systemic

2.5

179.5

1613

5891

Z3231

NOMESCO Finland

Registered nurse

1.9

177.9

3392

17282

N06AX16

ATC

venlafaxine; oral

2.2

177.7

2142

9054

X19

ICPC

Breast lump/mass female

7.2

176.5

463

562

A02BC02

ATC

pantoprazole; systemic

1.7

175.1

8426

57418

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

70.2

174.2

212

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

173.2

177

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

58.0

172.7

216

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

4.6

172.2

654

1252

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

168.3

172

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

167.3

171

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

14.9

167.2

298

173

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

1545.9

167.0

173

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.4

166.3

890

2314

M05BA02

ATC

clodronic acid; systemic

175.4

165.5

184

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

165.3

169

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

163.4

167

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

8.2

156.3

375

396

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

151.5

1603

6329

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.9

150.6

457

676

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

97.1

145.4

170

Z3226

NOMESCO Finland

Physiotherapist

1.9

144.1

2436

11722

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

143.7

147

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

5.0

139.1

485

845

TQW99

NOMESCO Finland

Other minor procedure on skin

3.8

137.4

649

1519

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

185.8

137.3

152

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.8

135.0

619

1412

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

134.9

138

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

133.9

137

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

102.1

133.3

155

L02BA02

ATC

toremifene; oral

+∞

133.0

136

X26

ICPC

Fear of breast cancer female

12.2

132.0

256

181

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

130.0

133

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

129.1

854

2570

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

128.4

1389

5512

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

4.9

127.1

454

812

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

125.1

128

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

125.1

128

3AA13

NOMESCO Finland

1103.3

124.0

129

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

13.6

123.6

228

144

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.3

123.1

676

1783

S18

ICPC

Laceration/cut

1.6

122.4

4734

29111

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

39.6

121.2

162

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

23.9

119.7

181

ZZR00

NOMESCO Finland

Flap of skin

13.6

118.9

219

138

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

222.5

118.8

130

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

532.5

118.4

125

A46

ICD-10 Finland

Erysipelas

2.1

117.2

1549

6707

128

Kela drug reimbursment

Cancers of female genital organs

354.1

116.8

125

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

116.3

119

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

115.3

118

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

114.4

117

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

111.4

114

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.4

110.5

595

1544

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

109.5

112

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

17.3

108.7

182

J01DB01

ATC

cefalexin; oral

1.6

108.4

9781

72848

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

107.5

110

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

107.5

110

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

107.4

1073

4075

J01MA12

ATC

levofloxacin; systemic

1.9

106.7

2002

9874

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

476.4

105.7

112

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

105.5

108

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

71.8

104.1

126

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

101.6

104

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.5

101.1

888

3152

ZSZ10

NOMESCO Finland

Secondary repair operation

138.9

101.0

114

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

100.7

522

9969

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

22.7

98.5

151

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

37.6

97.9

132

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

35.5

97.4

133

ZXE00

NOMESCO Finland

One hour or less

1.5

96.4

4564

28958

JN6AD

NOMESCO Finland

CT of torso and neck

17.9

96.2

159

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.3

95.8

313

506

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

94.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.3

92.2

263

359

QBJ00

NOMESCO Finland

Liposuction in trunk

10.5

91.2

189

154

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

90.9

676

2180

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

125.4

90.5

103

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

90.5

851

3127

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

90.4

941

3636

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

211.0

90.3

WW500

NOMESCO Finland

Blood transfusion

4.5

89.8

343

657

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

88.9

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

7.9

88.0

215

234

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

782.6

88.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

86.4

696

2350

9703

FHL

Breast resection

7.2

85.6

222

265

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

85.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

85.0

2109

11277

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

260.2

83.9

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.9

83.6

376

841

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

81.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

79.1

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

20.7

79.0

124

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

355.8

78.6

N62

ICD-10 Finland

Hypertrophy of breast

2.4

78.2

705

2527

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

78.2

1300

6091

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

78.1

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

78.1

WX110

NOMESCO Finland

Local anesthesy

1.4

78.1

7777

56468

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

347.2

76.7

SPAT1269

SPAT

Other puncture and/or drainage

11.5

75.2

149

111

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.1

75.2

159

135

SPAT1153

SPAT

Removal of sutures

1.5

73.4

3511

21982

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

73.3

HA1DA

NOMESCO Finland

Restricted mammography

47.1

73.0

QBA00

NOMESCO Finland

Puncture of skin of trunk

14.3

71.9

129

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

36.8

70.3

WX704

NOMESCO Finland

Intubation

2.2

69.5

804

3250

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

69.3

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

68.4

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

68.4

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

42.1

67.7

D05.0

ICD-10 Finland

Lobular carcinoma in situ

85.1

67.7

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

35.6

67.7

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

66.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

66.4

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

68.1

65.9

B29

ICPC

Lymph/immune mech sympt/complt other

12.0

65.8

127

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

204.0

65.6

HAD20

NOMESCO Finland

Liposuction of breast

31.0

64.9

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

62.5

9706

FHL

Ablation mammae, includes axillary exploration

+∞

62.5

5702

FHL

Local lymph node removal (eg armpit, groin)

30.9

62.0

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

146.6

61.5

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

29.6

61.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

61.3

10845

85545

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

15.2

61.3

107

N05CF01

ATC

zopiclone; oral

1.4

60.8

3861

25354

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

59.9

257

552

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

59.6

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.1

59.1

172

242

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

140.2

58.7

OAA41

NOMESCO Finland

Health check based on individual needs

113.9

58.5

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

57.6

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

57.6

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

56.9

1923

11030

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

41.9

56.4

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

55.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.2

55.2

313

843

WF099

NOMESCO Finland

Other radiotherapy

19.2

54.9

HAD00

NOMESCO Finland

Augmentation mammoplasty

34.9

54.4

N64.9

ICD-10 Finland

Disorder of breast, unspecified

4.5

54.3

205

390

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

53.7

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

53.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

25.5

53.1

D24

ICD-10 Finland

Benign neoplasm of breast

2.9

53.0

340

995

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

52.7

795

3573

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

52.7

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.6

52.5

254

606

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

52.3

326

936

HAA10

NOMESCO Finland

Biopsy of mammary gland

4.9

52.2

181

315

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

52.0

502

1861

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

465.7

52.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.9

51.9

154

223

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

51.7

695

2987

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

49.8

SPAT1152

SPAT

Removal of foreign body from under the skin

2.7

49.0

353

1115

1XC13

NOMESCO Finland

+∞

48.8

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

48.8

1CD01

NOMESCO Finland

+∞

48.8

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

8.0

48.6

116

123

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

116.7

48.2

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

47.8

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.6

47.2

1232

6589

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

423.0

47.2

A04AA03

ATC

tropisetron; systemic

50.1

46.6

SPAT1324

SPAT

Screening procedure

0.7

46.1

1551

18299

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

45.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

45.8

304

912

N61

ICD-10 Finland

Inflammatory disorders of breast

3.0

45.4

277

786

RD211

NOMESCO Finland

2.1

45.4

532

2155

A21

ICPC

Risk factor for malignancy

66.8

45.3

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

76.4

45.3

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

7.3

45.0

114

133

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

45.0

350

1157

XX2ET

NOMESCO Finland

+∞

44.9

5BX04

NOMESCO Finland

+∞

44.9

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

44.9

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

207.9

44.8

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.7

44.5

101

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

5.7

44.4

135

202

JN5AN

NOMESCO Finland

Total body isotope imaging

397.3

44.3

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

9.8

44.2

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

43.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

43.6

770

3655

XX9TE

NOMESCO Finland

Compementary ultrasound examination

6.4

43.4

120

159

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

43.4

4552

31967

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

43.2

813

3941

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

43.0

2268

14211

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

43.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

43.0

1DB03

NOMESCO Finland

+∞

42.0

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

42.0

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

42.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

42.0

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

42.0

ZZS55

NOMESCO Finland

Distension of tissue expander

195.1

42.0

A06AH03

ATC

naloxegol; oral

9.2

41.9

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

41.0

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

41.0

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

41.0

J94.8

ICD-10 Finland

Other specified pleural conditions

5.0

40.9

139

238

N05CB02

ATC

barbiturates in combination with other drugs

2.3

40.7

410

1552

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

40.1

564

2463

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

40.0

3030

Kela drug reimbursment

Abemaciclib

+∞

40.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

40.0

1515

Kela drug reimbursment

+∞

40.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

40.0

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.0

39.9

245

699

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

32.7

39.3

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

39.0

ZSZ00

NOMESCO Finland

Primary repair operation

124.4

38.9

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

16.2

38.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

346.1

38.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

346.1

38.4

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

42.4

38.4

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

38.3

295

970

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

38.1

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

38.1

1BC02

NOMESCO Finland

+∞

38.1

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

38.1

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

38.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

38.0

821

4150

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

37.9

484

2035

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

37.6

1152

6406

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

37.1

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

37.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

35.3

37.1

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.2

36.9

209

564

GA5AA

NOMESCO Finland

Rib X-ray examination

9.6

36.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

36.5

1233

7015

L95

ICPC

Osteoporosis

2.0

36.2

493

2128

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

169.6

36.2

QCJ00

NOMESCO Finland

Liposuction in upper limb

34.6

36.2

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.9

35.8

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.9

35.7

235

702

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

320.4

35.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

320.4

35.5

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

14.6

35.3

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

35.1

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

35.1

8524/3-C50.4

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

35.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

13.9

34.6

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

11.1

34.4

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

34.3

370

1444

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

59.5

34.2

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

34.2

L01EF03

ATC

abemaciclib; oral

+∞

34.2

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

34.2

C90.0

ICD-10 Finland

Multiple myeloma

110.2

34.2

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

84.8

34.1

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

5.3

33.9

109

176

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

156.8

33.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

33.2

156

Kela drug reimbursment

Lapatinib

+∞

33.2

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

33.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.2

33.2

131

263

ZX050

NOMESCO Finland

Stereotactic radiotherapy

14.5

33.0

M05BA04

ATC

alendronic acid; oral

1.5

32.9

1143

6537

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

32.7

712

3606

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

32.2

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

32.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

32.0

1906

12135

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

16.7

31.8

Z2221

NOMESCO Finland

Medical doctor

1.3

31.7

2844

19314

A08

ICPC

Swelling

1.9

31.7

469

2087

TPX15

NOMESCO Finland

Removal of vascular injection port

12.5

31.6

HA1AE

SPAT

2.6

31.6

235

759

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.6

31.5

476

6684

ZX001

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy

55.0

31.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.5

31.4

156

383

THA00

NOMESCO Finland

Needle biopsy of mamilla

11.8

31.3

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.8

31.3

102

L01XE07

ATC

[U] lapatinib; oral

+∞

31.2

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

31.2

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

+∞

31.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

31.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

31.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

31.2

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

31.2

M05BA06

ATC

ibandronic acid; systemic

2.2

30.9

329

1279

QBA10

NOMESCO Finland

Incision of skin of trunk

4.3

30.6

118

232

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

30.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

30.3

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

30.3

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

30.3

8522/3-C50.1

ICD-O-3

Infiltrating duct and lobular carcinoma of central portion of breast

+∞

30.3

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

30.3

R18

ICD-10 Finland

Ascites

3.8

30.1

133

297

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

269.1

29.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

29.5

4197

30227

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

29.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

29.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

29.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

29.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

29.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

29.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

264.8

28.8

HAA01

NOMESCO Finland

Suture of mammary gland

59.4

28.6

5BA08

NOMESCO Finland

5.6

28.5

133

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

28.3

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

28.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

28.3

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

28.2

156

417

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

39.2

28.2

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

6.9

28.1

WW200

SPAT

0.6

28.1

513

6894

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

256.0

27.8

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

32.2

27.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

57.5

27.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

27.6

496

2367

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

90.4

27.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

27.5

159

438

Z2446

NOMESCO Finland

Social worker

1.8

27.4

534

2615

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.9

27.4

178

530

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

27.3

WE200

NOMESCO Finland

Profylactive therapy of malignancy with hormones

+∞

27.3

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.9

27.3

117

255

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.5

27.2

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.7

27.1

122

277

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

27.1

715

3818

S77

ICPC

Malignant neoplasm of skin

14.0

27.1

ZX121

NOMESCO Finland

Central venous catheter

14.0

27.1

Z31.6

ICD-10 Finland

General counselling and advice on procreation

8.8

27.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

26.7

685

3632

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

87.6

26.6

C507

ICD-10 Finland

+∞

26.4

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

65.7

25.7

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.1

25.7

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

25.7

703

3792

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

25.4

182

576

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

25.4

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

25.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

25.4

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

25.4

L57.0

ICD-10 Finland

Actinic keratosis

1.6

25.3

730

3986

S76

ICPC

Skin infection other

1.8

25.2

469

2262

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

25.2

233

850

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

229.5

25.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.1

24.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

118.6

24.8

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

10.1

24.8

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

24.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

24.4

PJ5YQ

NOMESCO Finland

+∞

24.4

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

24.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.8

24.4

109

247

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

24.4

1258

7782

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

23.5

24.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

10.4

24.2

E0000UV

ATC

1.2

24.1

4255

31209

SPAT1211

SPAT

Application of soft bandage

1.5

24.1

869

5000

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

1.6

24.1

686

3736

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

18.9

24.1

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

31.1

24.0

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

6.4

23.9

A14AB01

ATC

nandrolone; parenteral

8.6

23.7

ZXD20

NOMESCO Finland

Day surgery

1.4

23.6

1406

8914

TJA10

NOMESCO Finland

Laparocentesis

16.5

23.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

23.5

1068

6446

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.6

23.5

527

6787

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

37.5

23.5

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

23.4

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.0

23.4

133

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

23.4

213

772

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.6

23.4

177

579

NK6SN

NOMESCO Finland

Bone SPECT

42.4

23.3

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

4.6

23.3

156

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.6

23.2

109

258

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

23.2

6858

62934

ZX100

NOMESCO Finland

Oral

3.2

23.2

124

325

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.0

23.0

300

1276

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

110.1

22.9

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

22.8

163

516

X79

ICPC

Benign neoplasm breast female

17.4

22.8

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

9.2

22.8

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

22.8

242

942

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

3.8

22.7

101

229

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.8

22.6

138

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

22.6

1391

8865

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

22.6

478

2399

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

22.5

922

5451

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

22.5

188

650

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

22.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

22.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

22.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

22.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

22.4

XX2VW

NOMESCO Finland

Radiologic consultation

4.8

22.3

137

ULC02

NOMESCO Finland

Hysteroscopy

1.5

22.3

745

4216

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

203.3

22.1

D75

ICPC

Malignant neoplasm colon/rectum

24.6

22.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

21.7

427

2098

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

21.7

190

675

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

19.2

21.7

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

19.2

21.7

9702

FHL

Breast exploration and possible tumor removal

2.2

21.6

220

842

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.2

21.5

118

316

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

21.5

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

21.5

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

21.5

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

21.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

20.9

692

3905

HA1S1

NOMESCO Finland

Photography of breasts

33.9

20.8

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

4.1

20.8

171

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

20.8

590

7259

B04

ICPC

Blood symptom/complaint

5.0

20.7

118

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

20.7

167

568

B01AB04

ATC

dalteparin; parenteral

1.7

20.6

439

2207

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.3

20.6

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

20.5

145

456

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.5

20.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

20.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

20.5

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

20.5

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

20.5

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

20.5

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

20.4

228

912

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

20.2

1368

8841

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

20.2

721

8523

C56

ICD-10 Finland

Malignant neoplasm of ovary

52.9

20.2

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

186.3

20.2

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

67.8

20.1

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

97.4

20.1

XX9XW

NOMESCO Finland

4.6

20.0

134

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.8

20.0

190

N02AA01

ATC

morphine; systemic, rectal

4.2

19.8

159

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

36.7

19.7

L01AX03

ATC

temozolomide; systemic

+∞

19.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

19.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

19.5

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

19.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

19.5

158

Kela drug reimbursment

Everolimus

+∞

19.5

X62

ICPC

Female Genital, Administrative procedure

+∞

19.5

ZXA10

NOMESCO Finland

Bilateral

1.3

19.4

1942

13264

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

19.2

327

1535

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

177.8

19.2

L71

ICPC

Malignant neoplasm musculoskeletal

177.8

19.2

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

65.0

19.2

WE100

NOMESCO Finland

Profylactic cytostatic therapy

65.0

19.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

19.0

365

1781

R60.0

ICD-10 Finland

Localized oedema

1.4

19.0

1063

6655

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

20.5

19.0

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.9

18.8

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

+∞

18.5

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

18.5

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

18.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

18.5

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

18.5

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

18.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

18.5

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

18.5

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

48.7

18.4

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

62.2

18.2

WE198

NOMESCO Finland

Palliative cystotatic therapy

62.2

18.2

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

30.3

18.2

ZX095

NOMESCO Finland

Combined chemoradiotherapy

88.9

18.2

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

88.9

18.2

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

19.8

18.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

6.3

18.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

18.0

157

559

9719

FHL

Other measure in this category

7.3

18.0

X77

ICPC

Malignant neopl genital female other

33.8

17.9

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

17.9

1149

12451

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

17.8

362

1798

S29

ICPC

Skin symptom/complaint other

1.3

17.8

1583

10642

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

17.7

140

473

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

17.7

780

4675

N05CF02

ATC

zolpidem; oral

1.3

17.7

1978

13685

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

5.7

17.6

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

17.6

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

17.6

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

17.6

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

17.6

8246/3-C50.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of breast, NOS

+∞

17.6

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

17.6

JAL30

NOMESCO Finland

Omentectomy

3.8

17.5

166

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

29.0

17.3

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

59.4

17.3

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

0.7

17.3

877

9819

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

160.8

17.3

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.2

17.2

136

L09

ICPC

Arm symptom/complaint

1.6

17.2

438

2320

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

17.0

1787

18264

J05AB11

ATC

valaciclovir; oral

1.3

17.0

1338

8835

HAB30

NOMESCO Finland

Excision of mamilla or areola

15.8

16.8

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.3

16.8

127

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

16.8

1049

11414

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

5.6

16.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

37.2

16.8

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.7

16.8

777

8819

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.3

16.8

221

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

16.6

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

16.6

L02AB01

ATC

megestrol; oral (progestogens)

+∞

16.6

8522/3-C50.8

ICD-O-3

Infiltrating duct and lobular carcinoma of overlapping lesion of breast

+∞

16.6

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

16.6

Z30.2

ICD-10 Finland

Sterilization

0.7

16.6

700

8059

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

0.6

16.6

294

3982

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

16.6

472

2573

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.9

16.5

254

1154

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

152.4

16.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

152.4

16.3

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

16.3

433

2321

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

31.1

16.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.6

16.0

115

370

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.0

15.8

210

904

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.2

15.8

159

609

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

15.8

2750

19953

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

15.8

314

1554

1AA01

NOMESCO Finland

17.6

15.7

OAB47

SPAT

0.4

15.7

1359

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.4

15.7

192

KMAK

NOMESCO Finland

0.9

15.7

4590

42800

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

15.6

3389

25101

M53.1

ICD-10 Finland

Cervicobrachial syndrome

0.7

15.6

704

8028

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

15.6

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

15.6

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

15.6

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

15.6

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

15.6

JFB30

NOMESCO Finland

Right hemicolectomy

4.2

15.6

121

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

15.4

2353

16834

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.4

15.4

107

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

143.9

15.4

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

143.9

15.4

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.9

15.3

218

962

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.3

15.3

139

507

J01FF01

ATC

clindamycin; systemic

1.2

15.2

2638

19125

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.2

15.1

153

587

C43

ICD-10 Finland

Malignant melanoma of skin

33.8

15.0

C03CA01

ATC

furosemide; systemic

1.2

15.0

2457

17699

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.0

5155

39670

A10AA02

ATC

0.4

14.9

1400

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

16.9

14.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

14.8

850

9359

WX707

NOMESCO Finland

Fiberoscopic intubation

7.6

14.8

B01AC04

ATC

clopidogrel; oral

0.7

14.8

644

7381

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

40.2

14.8

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

14.7

179

746

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

14.7

2039

20294

4CJ01

NOMESCO Finland

+∞

14.6

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

14.6

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

14.6

335

Kela drug reimbursment

Lapatinib

+∞

14.6

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

14.6

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

14.6

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

14.6

C50.62

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, lobular tumor

+∞

14.6

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

14.6

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

14.6

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

14.6

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

14.6

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

14.6

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

14.6

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

14.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.4

14.6

1473

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

50.8

14.6

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

50.8

14.6

G47.3

ICD-10 Finland

Sleep apnoea

0.8

14.5

1146

12117

N64.8

ICD-10 Finland

Other specified disorders of breast

3.3

14.5

191

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

135.4

14.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

135.4

14.4

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

135.4

14.4

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

3.6

14.4

152

S21

ICPC

Skin texture symptom/complaint

1.3

14.4

1080

7081

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

2.4

14.3

124

443

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.4

14.3

126

453

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.3

14.3

193

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.7

14.2

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.6

14.2

104

339

N05BA04

ATC

oxazepam; oral

1.2

14.2

2613

19027

ZZA50

NOMESCO Finland

Full thickness skin graft

9.1

14.1

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

4.2

14.1

109

L03.3

ICD-10 Finland

Cellulitis of trunk

3.2

14.1

195

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

16.2

14.1

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

0.4

14.0

1365

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

38.1

13.9

D77

ICPC

Malignant digestive neopl other/NOS

38.1

13.9

XX9CN

NOMESCO Finland

38.1

13.9

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

0.4

13.9

1409

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

13.9

1287

8684

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

9.9

13.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

19.7

13.8

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

5.3

13.7

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.7

13.7

277

1379

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

13.7

1XC14

NOMESCO Finland

+∞

13.7

8523/3-C50.2

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast

+∞

13.7

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

13.7

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

13.7

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

13.7

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

13.7

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

13.7

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

13.7

3002

Kela drug reimbursment

Ribociclib

+∞

13.7

OAB39

NOMESCO Finland

Sexual health guidance

+∞

13.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

13.7

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

13.7

L01XE10

ATC

[U] everolimus; oral

+∞

13.7

1514

Kela drug reimbursment

+∞

13.7

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

67.8

13.5

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

67.8

13.5

9710

FHL

Existence of a relapse

126.9

13.5

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

126.9

13.5

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

13.3

1395

9549

G43

ICD-10 Finland

Migraine

0.5

13.2

128

2017

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

13.2

393

2168

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

0.6

13.1

185

2643

L04AX01

ATC

azathioprine; systemic

0.5

13.1

141

2158

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.0

13.0

168

718

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

14.3

12.9

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

12.9

458

2630

TGA30

NOMESCO Finland

Thoracocentesis

4.5

12.8

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

12.7

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

12.7

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

12.7

8524/3-C50.2

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast

+∞

12.7

8507/3-C50.5

ICD-O-3

Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast

+∞

12.7

8523/3-C50.5

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast

+∞

12.7

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

+∞

12.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

12.7

WB213

NOMESCO Finland

Adjuvant hormone therapy of malignancy

+∞

12.7

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

12.7

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

12.7

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

12.7

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

118.5

12.5

L04AX04

ATC

lenalidomide; oral

118.5

12.5

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

12.5

442

2536

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

14.8

12.5

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

6.9

12.4

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

28.8

12.4

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

12.4

135

540

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

12.4

1687

11902

ZXD05

NOMESCO Finland

Urgent procedure

1.2

12.3

2576

18943

E66.8

ICD-10 Finland

Other obesity

0.6

12.3

236

3138

AN1

Coronary angiography

0.7

12.3

455

5355

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

12.3

116

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.3

12.3

1349

9292

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

12.2

4285

39685

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

12.2

532

3183

TQX05

NOMESCO Finland

Skin puncture, unspecified location

5.3

12.2

SGA01

NOMESCO Finland

Tooth opening as first aid

0.8

12.1

871

9323

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.8

12.1

732

8011

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.8

12.1

193

891

HAA00

NOMESCO Finland

Incision of mammary gland

6.3

12.1

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

6.3

12.1

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

0.7

12.0

392

4706

A10AA01

ATC

0.4

12.0

1041

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.6

11.9

339

1852

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

11.9

205

971

C10AA05

ATC

atorvastatin; oral

0.9

11.9

2942

27960

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

11.9

1241

8490

PJW20

NOMESCO Finland

Lymphovenous shunt

42.3

11.9

ZX002

NOMESCO Finland

Simple dose design for radiotherapy based on tomography - isocentric therapy

42.3

11.9

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

42.3

11.9

N81.6

ICD-10 Finland

Rectocele

0.7

11.8

624

6953

P01BA02

ATC

hydroxychloroquine; oral

0.7

11.8

600

6720

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

0.6

11.7

207

2802

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

11.7

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

11.7

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

11.7

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

11.7

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

11.7

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.7

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

11.7

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.7

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

11.7

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

11.7

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

11.7

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

11.7

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

11.7

C739

ICD-10 Finland

+∞

11.7

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

5.4

11.7

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

59.3

11.7

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.0

11.6

A07AA02

ATC

nystatin; oral

1.4

11.6

612

3793

HAC99

NOMESCO Finland

Other mastectomy

110.0

11.6

T71

ICPC

Malignant neoplasm thyroid

110.0

11.6

A26

ICPC

Fear of cancer, NOS

3.4

11.6

140

N06AX11

ATC

mirtazapine; oral

1.2

11.6

3395

25659

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

27.1

11.5

M77.1

ICD-10 Finland

Lateral epicondylitis

0.7

11.5

360

4353

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

11.5

3646

27721

J01MA02

ATC

ciprofloxacin; systemic

1.2

11.4

3643

27707

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.8

11.4

1534

15356

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

0.3

11.4

795

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.7

11.4

116

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

11.2

876

5772

R84

ICPC

Malignant neoplasm bronchus/lung

31.8

11.2

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

31.8

11.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

11.2

1334

9267

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.4

11.2

331

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

11.2

865

5690

SPAT1255

SPAT

Intravenous administration of medicine

1.4

11.1

488

2929

R06AE07

ATC

cetirizine; oral

1.1

11.1

4907

38176

N03AG01

ATC

valproic acid; systemic, rectal

0.6

11.1

247

3184

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.6

11.0

115

153

Kela drug reimbursment

Lenalidomid

39.5

11.0

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

39.5

11.0

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.4

11.0

826

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

11.0

108

1691

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

10.9

1325

13397

A02BC05

ATC

esomeprazole; systemic

1.1

10.9

4560

35337

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

10.9

5203

40683

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

10.8

286

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

10.8

1785

17547

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

10.8

221

1108

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

0.8

10.7

652

7133

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

10.7

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

10.7

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

10.7

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

10.7

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

10.7

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

10.7

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

10.7

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

+∞

10.7

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

10.7

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

10.7

8523/3-C50.8

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast

+∞

10.7

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

10.7

1XC0V

NOMESCO Finland

+∞

10.7

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

10.7

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

10.7

M03BC01

ATC

orphenadrine (citrate); systemic

0.8

10.7

1865

18252

A07EC01

ATC

sulfasalazine; oral, rectal

0.7

10.7

461

5295

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

0.7

10.7

258

3272

N81.1

ICD-10 Finland

Cystocele

0.8

10.6

629

6906

189

Kela drug reimbursment

Imatinib

101.5

10.6

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

101.5

10.6

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

101.5

10.6

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

101.5

10.6

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

101.5

10.6

C10AA07

ATC

rosuvastatin; oral

0.8

10.6

1880

18375

RF210

NOMESCO Finland

1.6

10.6

258

1355

S04

ICPC

Lump/swelling localized

1.3

10.6

784

5128

A87

ICPC

Complication of medical treatment

2.7

10.6

217

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

0.7

10.5

374

4428

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.9

10.5

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.5

10.5

275

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.5

10.5

100

1577

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

10.4

103

396

R5110

SPAT

1.6

10.4

236

1221

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

29.6

10.4

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.3

10.3

326

N05AX08

ATC

risperidone; systemic

0.7

10.3

341

4086

ZXC50

NOMESCO Finland

Cryotherapy

1.8

10.3

170

797

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

10.3

408

4745

ZXC82

NOMESCO Finland

Microsurgical

11.5

10.3

TGD00

NOMESCO Finland

Needle biopsy of lung

5.9

10.2

M54.2

ICD-10 Finland

Cervicalgia

0.7

10.2

386

4520

OAB42

SPAT

0.6

10.2

166

2284

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

10.1

808

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

10.1

201

998

L04AA13

ATC

leflunomide; oral

0.6

10.1

117

1753

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.9

10.1

139

610

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

10.1

588

3707

ZXF20

NOMESCO Finland

Interruption caused by problems of surgical technique

6.5

10.1

J05AB01

ATC

aciclovir; systemic

1.2

10.1

2198

16188

SPAT1229

SPAT

Assessment of need for aid

1.3

10.1

737

4813

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

0.8

10.0

623

6796

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

10.0

1540

10992

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

0.7

9.9

505

5656

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.3

9.9

126

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

9.9

332

1889

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

9.9

140

3AA02

NOMESCO Finland

50.8

9.8

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

5.9

9.8

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.0

9.8

115

477

C54.23

ICD-10 Finland

Carcinosarcoma

+∞

9.8

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

9.8

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

9.8

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

9.8

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

9.8

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

9.8

HAF99

NOMESCO Finland

Other operation for local recurrence of breast cancer

+∞

9.8

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

9.8

8507/3-C50.1

ICD-O-3

Invasive micropapillary carcinoma of breast of central portion of breast

+∞

9.8

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

9.8

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

9.8

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

9.8

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

9.8

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

9.8

340

Kela drug reimbursment

Everolimus

+∞

9.8

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

9.8

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

9.8

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

9.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

9.8

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

9.8

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

9.8

8523/3-C50.1

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of central portion of breast

+∞

9.8

SAA01

NOMESCO Finland

Simple examination of mouth

0.9

9.7

6925

61681

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

8.5

9.7

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

93.1

9.7

R31

NOMESCO Finland

Adaptation training

6.4

9.7

GEA00

NOMESCO Finland

Mediastinoscopy

4.3

9.6

ZZS50

NOMESCO Finland

Insertion of tissue expander

27.5

9.5

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

27.5

9.5

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

9.4

205

1049

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

9.5

9.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.8

9.4

1099

11155

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.7

9.3

OAB44

SPAT

0.6

9.3

108

1614

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.0

9.3

110

459

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

9.3

1344

N39.3

ICD-10 Finland

Stress incontinence

0.8

9.3

666

7136

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

9.3

428

4863

L91.0

ICD-10 Finland

Hypertrophic scar

2.2

9.3

382

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.7

9.2

425

4828

A55

ICPC

General and Unspecified, Local injection/infiltration

2.5

9.2

238

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

5.9

9.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

9.1

1401

13869

C10AX09

ATC

ezetimibe; oral

0.8

9.1

582

6322

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.8

9.0

173

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

9.0

1141

7977

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.7

9.0

207

2645

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.7

9.0

216

2736

ZZR70

NOMESCO Finland

Perforator flaps

22.0

9.0

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

16.9

8.9

L04AB01

ATC

etanercept; parenteral

0.4

8.9

703

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

8.9

206

2631

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.5

8.9

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.8

8.8

171

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.8

8.8

148

701

B02.9

ICD-10 Finland

Zoster without complication

1.4

8.8

499

3138

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

8.8

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

8.8

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

8.8

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

8.8

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

8.8

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

8.8

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

8.8

1XC07

NOMESCO Finland

+∞

8.8

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

8.8

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

8.8

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

8.8

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

8.8

HAF10

NOMESCO Finland

Repair after excision of local recurrence of breast cancer using graft or flap

+∞

8.8

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

8.8

197

Kela drug reimbursment

Sunitinib

+∞

8.8

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

8.8

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

8.8

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

8.8

8523/3-C50.3

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast

+∞

8.8

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

+∞

8.8

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

8.8

C54.13

ICD-10 Finland

Clear cell carcinoma of the endometrium

+∞

8.8

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

8.8

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

8.8

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

8.8

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

8.8

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

8.8

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

8.8

00044

NOMESCO Finland

+∞

8.8

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

8.8

20199

ICD-8 Finland

Hodgkin's disease

+∞

8.8

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

8.8

SGC00

NOMESCO Finland

Local medication of root channels of tooth

0.8

8.8

577

6248

A06AD11

ATC

lactulose; oral

1.2

8.8

1147

8045

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

8.8

393

4484

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

84.6

8.8

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

84.6

8.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.6

8.7

168

2226

JAL31

NOMESCO Finland

Laparoscopic omentectomy

5.2

8.7

WX002

NOMESCO Finland

Sedation and analgesia

1.2

8.7

1835

13472

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

11.3

8.7

RF190

NOMESCO Finland

11.3

8.7

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.6

8.7

ZZA00

NOMESCO Finland

Split skin graft

1.8

8.7

145

687

RS220

NOMESCO Finland

2.2

8.7

343

X18

ICPC

Breast pain female

1.8

8.6

146

695

R83

ICPC

Respiratory infection other

0.8

8.6

1568

15308

N05AX12

ATC

aripiprazole; systemic

0.6

8.6

1401

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.9

8.5

1667

16188

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

14.8

8.5

ZYC01

SPAT

0.7

8.5

215

2700

K08.80

ICD-10 Finland

Toothache NOS

0.7

8.5

440

4914

S15

ICPC

Foreign body in skin

1.4

8.5

473

2966

103

Kela drug reimbursment

Diabetes, insulin-treated

0.9

8.5

1698

16462

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

0.7

8.5

283

3376

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.5

8.4

874

9724

FHL

Breast augmentation or reconstruction with own tissue

7.7

8.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

4.2

8.4

9721

FHL

Mamilla reconstruction or transposition

10.4

8.4

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

8.3

715

7502

S70

ICPC

Herpes zoster

1.6

8.3

213

1139

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

31.0

8.3

JN4DD

NOMESCO Finland

Scout CT scan of torso

31.0

8.3

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

31.0

8.3

-54

ICPC

Repair/fix-suture/cast/prosth device

1.6

8.3

200

1053

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.0

8.3

132

R4190

NOMESCO Finland

Nutritional therapy

1.7

8.3

170

857

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.3

8.3

277

GAC00

NOMESCO Finland

Biopsy of pleura

6.0

8.2

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

0.8

8.2

924

9422

N02AX02

ATC

tramadol; systemic, rectal

1.1

8.2

4100

31969

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

2.4

8.2

248

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

0.7

8.2

333

3849

H01CB03

ATC

lanreotide; parenteral

13.2

8.2

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

20.3

8.1

PJD99

NOMESCO Finland

Excision of other lymph nodes

20.3

8.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.7

8.1

423

4719

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

5.6

8.1

SPAT1151

SPAT

Treatment of major wounds

2.1

8.1

339

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

2.8

8.1

155

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

8.1

1099

11007

R03AC02

ATC

salbutamol; inhalant

0.9

8.1

5144

46325

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

0.7

8.1

350

4007

I25.2

ICD-10 Finland

Old myocardial infarction

0.6

8.1

121

1692

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

5.8

8.1

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

2.1

8.0

352

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

0.4

8.0

649

V03AF03

ATC

calcium folinate; systemic

42.3

8.0

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

42.3

8.0

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

42.3

8.0

N60.8

ICD-10 Finland

Other benign mammary dysplasias

2.8

8.0

143

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

6.5

8.0

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

7.0

7.9

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.7

7.9

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.2

7.9

1291

9257

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

0.7

7.9

177

2270

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

7.9

1346

13221

WZA10

NOMESCO Finland

Long statement of health and health related matters

1.9

7.9

111

497

SPAT1193

SPAT

Pap smear

0.8

7.8

630

6656

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

76.2

7.8

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

76.2

7.8

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

76.2

7.8

C01DA14

ATC

isosorbide mononitrate; oral

0.8

7.8

693

7242

NE049

NOMESCO Finland

Radiotherapy of methastasis in pelvis, sacrum or coggyx

+∞

7.8

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

+∞

7.8

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

7.8

C50.60

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, no histological veryfication

+∞

7.8

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

7.8

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

7.8

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

7.8

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

7.8

HAD41

NOMESCO Finland

Transposition of areola

+∞

7.8

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

7.8

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

7.8

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

7.8

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

7.8

L01XE01

ATC

[U] imatinib; oral

+∞

7.8

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

7.8

18099

ICD-8 Finland

Malignant neoplasm of cervix uteri

+∞

7.8

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

7.8

WC135

NOMESCO Finland

Very demanding cytostatic therapy of local tumor recidive

+∞

7.8

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

7.8

L01CB01

ATC

etoposide; systemic

+∞

7.8

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

7.8

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

7.8

8522/3-C50.3

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast

+∞

7.8

ZXH09

SPAT

0.5

7.8

897

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.5

7.8

ZZR30

NOMESCO Finland

Flap of muscle

3.9

7.8

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

6.3

7.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.7

7.8

264

3141

SPAT1283

SPAT

Restricted health certificate

0.8

7.7

954

9646

ZXC96

NOMESCO Finland

Robot assisted procedure

2.3

7.7

262

W78

ICPC

Pregnancy

0.6

7.7

132

1793

T89

ICPC

Diabetes insulin dependent

0.6

7.7

1395

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

4.7

7.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

7.7

2229

16764

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

7.7

343

2074

E83.50

ICD-10 Finland

Hypercalcemia

1.9

7.6

109

489

R03DC03

ATC

montelukast; oral

0.8

7.6

1290

12683

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.6

7.6

142

1893

M54.5

ICD-10 Finland

Low back pain

0.9

7.6

2837

26367

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.1

7.6

326

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

7.6

297

1751

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.8

7.6

L04

ICPC

Chest symptom/complaint

1.3

7.6

500

3223

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.8

7.5

431

4749

H02AB04

ATC

methylprednisolone; systemic

0.8

7.5

1117

11106

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.0

7.5

426

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

7.5

220

2685

ZZS00

NOMESCO Finland

Rotation flap

10.8

7.5

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.2

7.5

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

1.8

7.5

121

568

SPAT1308

SPAT

Sexual health counselling

0.7

7.4

245

2929

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

7.4

523

3403

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

0.5

7.4

929

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.5

7.4

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

12.2

7.4

C44

ICD-10 Finland

Other malignant neoplasms of skin

9.1

7.4

LCD30

NOMESCO Finland

Radical hysterectomy

9.1

7.4

GA1CG

NOMESCO Finland

Extensive MRI of chest

5.2

7.4

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

7.4

S50

ICPC

Skin, Medication/prescr/renewal

2.4

7.4

218

Z10.0

ICD-10 Finland

Occupational health examination

0.7

7.4

206

2532

R51.80

ICD-10 Finland

Headache

0.8

7.3

986

9889

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

14.5

7.3

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

18.6

7.3

HA1AT

SPAT

7.2

7.3

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

5.4

7.3

R06.5

ICD-10 Finland

Mouth breathing

0.7

7.2

365

4088

JLC30

NOMESCO Finland

Pancreatoduodenectomy

5.6

7.2

X81

ICPC

Genital neopl female other/unspecif

5.6

7.2

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.1

7.2

100

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

2.2

7.2

249

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

7.2

858

5962

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.5

7.1

260

1511

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

3.5

7.1

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

38.0

7.1

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.1

217

1215

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

7.1

1187

11685

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

0.7

7.1

239

2847

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

6.3

7.1

LCA10

NOMESCO Finland

Curettage of body of uterus

1.4

7.1

306

1839

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.7

7.1

325

3689

C10AA01

ATC

simvastatin; oral

0.9

7.1

3561

32552

NF1AA

NOMESCO Finland

Hip X-ray examination

1.2

7.1

778

5360

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

0.2

7.0

275

I20.09

ICD-10 Finland

Unstable angina

0.7

7.0

180

2249

G44.2

ICD-10 Finland

Tension-type headache

0.8

7.0

1010

10068

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.0

7.0

114

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.7

7.0

181

2260

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.4

7.0

198

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

0.7

6.9

207

2515

-44

ICPC

Preventive immunization/medic

1.3

6.9

681

4631

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

21.1

6.9

Y16

ICPC

Breast symptom/complaint male

21.1

6.9

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

0.7

6.9

317

3598

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

1.5

6.9

232

1326

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

67.7

6.9

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

6.5

6.9

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.8

6.9

367

4080

L04AB04

ATC

adalimumab; parenteral

0.5

6.9

827

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

4.0

6.9

M79.7

ICD-10 Finland

Fibromyalgia

0.7

6.9

199

2428

TGC00

NOMESCO Finland

Bronchial lavation

1.6

6.8

154

801

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

1.9

6.8

101

463

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

6.8

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

6.8

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

6.8

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

6.8

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

6.8

C79.1

ICD-10 Finland

Secondary malignant neoplasm of bladder and other and unspecified urinary organs

+∞

6.8

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

6.8

C51.21

ICD-10 Finland

Squamous cell carcinoma of the clitoris

+∞

6.8

185

Kela drug reimbursment

docetaxel

+∞

6.8

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

6.8

C50.6

ICD-10 Finland

Malignant neoplasm: Axillary tail of breast

+∞

6.8

C79.40

ICD-10 Finland

Secondary malignant tumor of the spinal cord

+∞

6.8

9920/3-C42.1

ICD-O-3

Therapy-related myeloid neoplasm of bone marrow

+∞

6.8

8500/3-C50.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of nipple

+∞

6.8

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

6.8

WC225

NOMESCO Finland

Demanding therapy of local tumor recidive with hormone

+∞

6.8

173

Kela drug reimbursment

Trastuzumab injection

+∞

6.8

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.8

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

6.8

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

6.8

8507/3-C50.2

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-inner quadrant of breast

+∞

6.8

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

6.8

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

6.8

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

6.8

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

6.8

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

+∞

6.8

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

6.8

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

6.8

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

6.8

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

6.8

L02BG01

ATC

aminoglutethimide; oral

+∞

6.8

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

+∞

6.8

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.8

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

6.8

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

6.8

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

6.8

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

6.8

8530/3-C50.4

ICD-O-3

Inflammatory carcinoma of upper-outer quadrant of breast

+∞

6.8

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

6.8

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

6.8

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

6.8

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.8

L01EF02

ATC

ribociclib; oral

+∞

6.8

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

6.8

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

6.8

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

6.8

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

6.8

M01AH05

ATC

etoricoxib; oral

0.9

6.8

6166

54738

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.8

128

631

SPAT1379

SPAT

Health check-up of pregnant person

0.6

6.8

1153

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.8

6.8

611

6375

G03FB01

ATC

norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.5

6.7

223

1274

N06DX01

ATC

memantine; oral

0.7

6.7

233

2760

HA1AA

SPAT

1.7

6.7

141

718

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

3.6

6.7

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

1.9

6.7

411

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.2

6.7

250

JFF23

NOMESCO Finland

Transversostomy

3.4

6.7

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

6.7

687

7068

G03DC05

ATC

[U] tibolone; oral

1.3

6.7

616

4155

2506

FHL

Thyroidectomy

4.8

6.7

S26

ICPC

Fear of cancer of skin

2.2

6.7

264

L06

ICPC

AXILLA SYMPTOMS/COMPLAINTS

7.5

6.7

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

0.6

6.6

1223

D70.81

ICD-10 Finland

Neutropenia congenital

11.3

6.6

NK6BT

NOMESCO Finland

Bone biopsy with X-ray guidance

11.3

6.6

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

5.4

6.6

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.0

6.6

M48.0

ICD-10 Finland

Spinal stenosis

0.8

6.6

810

8191

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

0.8

6.6

395

4319

E34.0

ICD-10 Finland

Carcinoid syndrome

25.4

6.6

EFA20

NOMESCO Finland

Decortication of jaws

25.4

6.6

329

Kela drug reimbursment

Lenalidomide

25.4

6.6

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

25.4

6.6

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

25.4

6.6

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

25.4

6.6

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

0.8

6.6

568

5948

E000006

ATC

1.2

6.5

714

4914

318

Kela drug reimbursment

Teriparatide

0.2

6.5

296

XX3XT

NOMESCO Finland

Other labeling with other radiological guidance

16.9

6.5

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.8

6.5

803

8111

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

0.3

6.5

411

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3018418) pH of Serum or Plasma

5850

29977

1.96

311.47

4.6

3.1

7.4

8.26

1489

5032

(40768804) Tissue Pathology biopsy report

8717

38998

2.95

307.65

2.4

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13865

77810

7.21

307.65

12.2

5.4

u/l

78.4

75.9

9.40

13652

71966

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1332

1755

6.66

307.65

1.2

1.3

—

(3023368) Bacteria identified in Blood by Culture

4697

20503

2.25

307.65

3.9

3.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

11519

54379

4.14

307.65

13.0

6.6

e9/l

3.5

4.0

159.52

10674

46809

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2208

7018

2.82

307.65

1.7

2.1

g/l

0.2

18.93

2125

6402

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4561

20206

2.20

307.65

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

6593

26785

2.78

307.65

2.0

—

(40758558) Short blood count panel - Blood

6420

23301

3.17

307.65

9.5

4.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

3612

264

146.08

307.65

4.3

1.2

u/ml

42.2

25.8

1.91

3496

243

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8737

41382

2.72

307.65

3.6

3.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

2098

171

115.64

307.65

4.8

1.1

u/ml

56.2

21.0

10.60

2083

161

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

868

118.61

307.65

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

880

998

7.54

307.65

1.4

1.2

nmol/l

0.2

0.4

4.26

542

723

(1617658) Protocol used for examination of sentinel lymph nodes

1848

610.92

307.65

1.0

—

(3002256) Pathology report gross observation

4357

8921

5.18

307.65

1.3

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11673

47801

5.49

307.65

9.9

3.5

umol/l

9.2

10.4

36.56

11446

44403

(40768793) Breast Pathology biopsy report

3485

1074

34.03

307.65

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

627

227

23.35

307.65

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4105

5513

7.95

307.65

4.1

1.5

ug/l

14.3

9.8

0.66

3174

4058

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2192

6249

3.16

307.65

2.9

1.5

u/ml

48.4

26.1

6.84

2122

5967

(4035726)

4936

3125

18.65

307.65

1.4

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

499

132

31.70

307.65

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8572

33374

3.54

307.65

6.7

2.1

mmol/l

2.4

51.45

7929

28048

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9319

50245

2.34

307.65

6.8

5.1

mmol/l

1.2

17.48

7656

42250

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8550

44962

2.27

307.65

5.5

4.6

mmol/l

1.2

32.37

8005

39820

(3024561) Albumin [Mass/volume] in Serum or Plasma

7320

40963

1.88

293.13

3.8

3.5

g/l

35.7

36.2

11.53

6840

37319

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1954

7923

2.15

185.08

4.4

2.8

mmol/l

1.2

6.36

1829

6644

(3042936) Bacteria identified in Isolate by Culture

2474

11348

1.92

165.38

1.8

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7727

48542

1.60

163.72

2.2

2.3

nmol/l

82.4

1975.0

0.50

7162

43269

(3033658) Prothrombin time (PT) actual/Normal

4144

22791

1.66

146.67

3.3

3.2

95.3

95.7

0.35

4043

22050

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3548

18796

1.70

144.37

3.0

2.2

mmol/l

2.5

26.26

3194

16099

(3003694) ABO and Rh group [Type] in Blood

3998

21901

1.66

143.03

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13419

98678

2.02

141.87

17.8

10.3

ml/min/173m2

80.3

79.2

10.96

12177

79362

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

626

1753

2.98

127.79

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13752

103011

2.05

119.42

16.9

11.5

mg/l

21.2

19.6

6.67

11419

78919

(3019225) pH of Specimen

2100

10261

1.77

110.66

4.7

3.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1855

8936

1.78

101.97

3.4

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2555

13515

1.64

99.58

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

440

1165

3.13

98.64

1.2

1.1

u/l

60.2

58.2

0.33

278

780

(3032080) INR in Blood by Coagulation assay

5685

35905

1.46

98.08

7.2

7.5

inr

1.2

0.69

1727

10264

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

130

117

9.08

95.94

5.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

14106

108035

2.07

88.87

16.9

13.1

mmol/l

139.8

139.9

5.40

13887

105021

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

532

1675

2.64

87.09

1.4

1.3

u/l

43.0

38.2

2.07

500

1269

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

612

2090

2.43

84.67

2.6

2.0

u/ml

1257.8

134.4

0.92

499

1679

(3023103) Potassium [Moles/volume] in Serum or Plasma

14111

108352

2.02

83.13

17.1

13.2

mmol/l

3.9

4.48

13872

105121

(3013826) Glucose [Moles/volume] in Serum or Plasma

8106

55978

1.38

76.88

3.7

3.8

mmol/l

6.5

6.6

3.14

7721

51941

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

208

402

4.24

73.68

1.3

1.1

ug/l

1.7

2.1

1.32

106

281

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2398

13337

1.55

73.24

2.9

2.3

mmol/l

0.8

4.08

2222

12139

(42870588) Differential panel, method unspecified - Blood

5078

32691

1.39

72.26

4.7

5.6

—

(40768806) Pleura Pathology biopsy report

202

389

4.26

71.89

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1163

5420

1.80

70.08

1.5

1.3

iu/l

41.4

37.9

2.79

1010

4780

(3044889) 12 lead EKG panel

10166

73396

1.39

69.69

3.7

3.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14301

111021

2.06

68.61

15.9

9.1

u/l

24.4

23.9

1.92

14095

106547

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

235

557

3.46

62.82

1.2

1.1

u/l

73.9

78.0

0.38

211

424

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

235

560

3.44

62.31

1.2

1.1

u/l

18.0

21.2

0.48

209

411

(3003434) Protein [Mass/volume] in Pleural fluid

238

581

3.36

60.83

1.4

g/l

35.9

29.5

11.54

220

500

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4849

31821

1.35

57.72

4.1

2.6

u/l

36.1

31.1

2.20

4618

30000

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

172

349

4.03

57.29

1.7

1.3

ug/l

18.2

28.2

0.65

166

339

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

256

692

3.04

55.47

1.6

1.5

u/l

5.5

6.7

0.48

127

320

(3004809) Band form neutrophils/100 leukocytes in Blood

333

1044

2.62

54.95

2.1

2.8

2.5

1.0

7.40

253

798

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

354

1169

2.49

52.56

2.8

1.9

u/ml

166.2

124.0

0.24

324

1048

(3019069) Monocytes/100 leukocytes in Blood

6663

46319

1.30

50.74

5.1

6.0

8.6

8.3

11.42

6236

42988

(3002030) Lymphocytes/100 leukocytes in Blood

6810

47499

1.30

50.48

5.0

5.8

27.1

29.5

49.91

6327

43817

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1672

9262

1.52

50.46

1.6

—

(4281824)

266

777

2.81

50.28

1.1

—

(3013512) EKG study

4528

29911

1.33

49.67

3.9

3.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

427

1574

2.24

49.55

1.3

1.4

—

(3021589) Normoblasts [#/volume] in Blood

6389

44259

1.30

49.51

10.9

8.1

e9/l

0.0

2.53

5267

36226

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1668

9276

1.52

49.35

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

524

2118

2.04

48.08

1.5

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

409

1502

2.24

47.89

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

6610

46135

1.29

47.71

4.9

5.7

2.7

2.9

10.66

6148

42546

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11853

101805

0.73

46.60

3.8

4.1

mmol/l

1.3

2.53

10540

93312

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

326

1097

2.44

46.53

1.4

—

(3012441) Differential panel - Pleural fluid

176

424

3.40

46.00

1.4

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12370

105485

0.72

45.67

4.3

4.6

mmol/l

1.6

2.31

11128

97512

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

229

656

2.86

44.89

1.2

u/l

16.0

19.8

0.59

204

558

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12485

106230

0.72

44.18

4.3

4.6

mmol/l

4.9

0.78

11291

98632

(3022096) Basophils/100 leukocytes in Blood

6392

44700

1.28

44.17

4.9

5.8

0.7

0.08

5949

41228

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

231

671

2.82

44.16

1.2

u/l

70.4

79.8

0.94

212

588

(3023199) Leukocytes [#/volume] in Pleural fluid

201

540

3.05

44.09

1.4

e6/l

4509.2

3694.4

0.10

149

390

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

436

1704

2.11

43.74

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

436

1704

2.11

43.74

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

749

3515

1.77

43.62

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

222

4.34

43.39

1.9

2.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12766

108132

0.71

42.34

4.8

5.1

mmol/l

2.9

4.84

11473

99981

(3028308) Erythrocytes [#/volume] in Pleural fluid

180

473

3.11

41.01

1.4

1.5

e6/l

32568.1

44273.2

0.30

103

268

(3018010) Neutrophils/100 leukocytes in Blood

6642

46968

1.27

40.60

4.8

5.7

57.1

56.3

6.10

6191

43509

(3007853) Bacteria identified in Skin by Aerobe culture

1811

10628

1.44

40.27

1.6

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

613

2785

1.82

39.75

2.6

3.0

—

(3051651) Icteric interference index of Serum or Plasma

164

419

3.20

39.15

2.4

3.7

—

(3002582) Erythrocytes [#/volume] in Urine

4088

27371

1.29

38.32

2.8

2.9

e6/l

86.6

69.2

0.27

3020

20423

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

677

3218

1.74

37.66

1.7

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

3806

25351

1.29

36.84

2.7

2.9

e6/l

0.5

0.4

1.64

2777

18738

(3031040) Bacteria [#/volume] in Urine by Automated count

9224

68223

1.25

36.20

4.7

4.6

e6/l

1103.1

2385.9

1.22

805

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

150

383

3.20

35.88

1.3

u/l

444.1

355.9

0.27

142

351

(3002385) Erythrocyte distribution width [Ratio]

11239

85153

1.29

35.73

22.4

13.8

13.6

22.02

11133

83112

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

334

1274

2.15

35.70

1.4

—

(36304419) Bacteria [Presence] in Urine

3722

24828

1.29

35.33

2.7

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2251

14011

1.36

34.91

2.6

e6/l

3.9

5.0

2.83

1123

7275

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

574

2663

1.78

34.71

1.8

ug/l

2.1

2.2

0.07

492

2273

(3026008) Bacteria identified in Urine by Culture

5027

34888

1.25

34.12

3.3

3.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

922

4875

1.57

33.81

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2090

21821

0.74

33.26

1.2

1.3

u/ml

9.8

12.9

1.42

778

8545

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4736

32724

1.26

33.15

2.8

3.1

—

0.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2197

22696

0.75

32.35

1.3

iu/ml

33.4

38.1

0.68

697

7529

(3045788) Cell count panel - Pleural fluid

153

423

2.95

32.08

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

596

2861

1.72

32.00

1.4

pmol/l

118.2

72.5

3.32

583

2803

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1328

7680

1.44

31.55

3.4

2.7

u/l

266.4

240.2

3.30

1248

7110

(3026782) Osmolality of Urine

2705

17528

1.31

31.43

2.5

2.6

mosm/kgh2o

500.6

505.0

0.50

2301

14625

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

299

1160

2.11

30.67

1.2

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

823

4345

1.57

30.33

4.5

6.1

mmol/l

25.2

25.1

0.15

811

4303

(3017181) Myelocytes/100 leukocytes in Blood

1336

7807

1.43

29.92

2.9

3.9

1.9

0.7

19.54

522

1471

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

197

651

2.47

29.38

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3587

24278

1.26

29.20

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

5.46

28.32

1.5

1.2

nmol/l

0.2

0.4

0.87

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1137

6516

1.45

28.24

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

237

869

2.23

28.01

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

442

6082

0.58

27.90

1.5

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

208

724

2.35

27.74

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

147

433

2.77

27.57

1.3

1.2

mmol/l

6.4

6.9

1.35

136

393

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

163

510

2.61

27.23

4.7

1.2

u/ml

111.3

261.0

1.35

117

(3018095) Leukocytes [#/volume] in Urine

4787

33676

1.23

26.93

3.3

3.4

e6/l

103.9

114.8

0.43

3251

22674

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

375

5336

0.56

26.77

1.5

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

7.43

26.77

1.4

3.7

mg/l

1.2

2.0

0.68

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11659

98945

0.80

25.56

5.4

5.7

mmol/mol

39.5

39.4

0.49

10564

91492

(3037522) Nuclear Ab [Titer] in Serum

1570

16478

0.75

24.99

1.3

1.4

titre

542.5

607.1

0.75

347

3773

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

176

600

2.40

24.63

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

176

600

2.40

24.63

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

176

600

2.40

24.63

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

749

8875

0.67

24.48

1.3

1.4

—

(3013115) Eosinophils [#/volume] in Blood

7055

51849

1.20

24.33

4.9

5.7

e9/l

0.2

18.96

6052

45613

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1392

8517

1.36

23.49

2.4

3.2

ng/l

71.9

82.0

6.52

1199

7172

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

353

2.80

23.18

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

353

2.80

23.18

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

353

2.80

23.18

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

355

2.78

22.94

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

177

634

2.28

22.21

3.5

1.5

nmol/l

4.7

3.6

0.49

171

595

(40761511) CBC panel - Blood by Automated count

13696

107915

1.36

22.19

16.0

11.1

—

(3019198) Lymphocytes [#/volume] in Blood

6940

51190

1.19

22.08

4.8

5.6

e9/l

1.7

1.9

31.05

5968

45156

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

104

288

2.94

21.90

1.2

1.3

u/l

11.9

11.8

0.02

248

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

189

704

2.19

21.62

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

133

423

2.56

21.61

1.4

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

1243

7575

1.36

21.45

2.9

4.0

0.3

0.1

11.50

472

1385

(40768441) Liver Pathology biopsy report

155

542

2.33

20.59

1.1

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

257

2.98

20.27

1.4

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

257

2.98

20.27

1.4

1.3

—

(3008898) HLA-B27 [Presence]

261

3803

0.55

20.26

1.1

—

(3006315) Basophils [#/volume] in Blood

6771

50074

1.18

20.13

4.8

5.6

e9/l

0.0

4.79

5744

43316

(3001604) Monocytes [#/volume] in Blood

6731

49823

1.17

19.58

4.8

5.6

e9/l

0.5

0.6

1.71

5712

43116

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

149

525

2.32

19.48

1.5

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1179

7232

1.35

19.46

2.9

3.7

1.3

0.5

10.57

358

1103

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

265

2.89

19.24

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.97

19.22

1.3

1.4

ug/l

636.4

33.3

0.91

(3051611) Lipemic interference index of Serum or Plasma

234

997

1.92

18.71

2.6

3.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

10.38

18.63

4.3

1.1

estimate

0.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1088

6636

1.36

18.62

4.5

5.9

mmol/l

1.3

0.62

1052

6411

(3019832) Treponema pallidum Ab [Presence] in Serum

299

4100

0.58

18.59

1.2

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1284

8030

1.33

18.57

3.7

2.2

ml/min/173m2

67.4

65.9

0.80

530

3111

(3008757) Leukocyte morphology finding [Identifier] in Blood

189

753

2.05

18.27

2.2

2.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12472

104442

0.81

18.21

4.5

4.7

mmol/l

5.9

5.8

2.89

11165

95784

(3019150) Specific gravity of Urine by Refractometry

2423

23297

0.81

18.00

4.0

4.5

kg/l

1.0

1.07

391

3597

(3014576) Chloride [Moles/volume] in Serum or Plasma

1528

9849

1.29

17.65

5.0

5.7

mmol/l

104.3

104.1

1.33

1499

9626

(3035880) pH of Pleural fluid

243

2.88

17.57

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

824

4852

1.40

17.50

1.4

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

176

708

2.03

16.63

2.2

2.6

56.5

59.5

0.79

106

467

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

142

3.44

16.39

1.3

72.6

56.7

3.00

113

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

195

2899

0.54

16.27

1.3

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

388

1998

1.59

16.00

2.4

3.2

u/ml

0.4

0.65

235

1192

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

268

3629

0.59

15.89

1.3

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2313

15810

1.22

15.86

2.4

2.5

e6/l

2.9

1.3

0.57

1180

9003

(3000919) Neutrophils/100 leukocytes in Pleural fluid

115

3.68

15.69

1.3

9.9

23.5

3.83

104

(3010421) pH of Blood

404

2117

1.56

15.47

3.2

3.3

7.4

2.75

327

1728

(3048689) Calprotectin [Mass/mass] in Stool

1365

13772

0.78

15.45

2.0

2.1

ug/g

120.7

115.4

0.23

1020

10578

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1123

7085

1.31

15.19

5.7

6.8

g/l

118.3

120.4

3.65

1079

6803

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.80

15.18

1.2

1.1

ug/l

18.2

2.7

0.45

(3020630) Protein [Mass/volume] in Serum or Plasma

1122

7081

1.31

15.14

2.5

1.5

g/l

66.5

67.0

1.25

997

6265

(3045142) Bone marrow Pathology biopsy report

149

584

2.08

15.14

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

1349

8725

1.28

15.09

5.2

6.1

mmol/l

1.2

1.4

1.19

1113

6863

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

386

2016

1.57

15.01

2.0

2.5

g/l

3.5

3.6

0.58

372

1899

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1352

8754

1.28

14.98

5.2

6.1

kpa

5.2

5.1

2.04

1287

8340

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

449

5348

0.67

14.96

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1351

8751

1.28

14.92

5.2

6.1

kpa

13.5

12.1

13.12

1287

8329

(3013727) Leukocytes other/100 leukocytes in Blood

190

2.96

14.82

1.8

3.4

49.8

54.3

0.71

184

(1761868) Lipid panel - Serum or Plasma

4175

37740

0.86

14.78

2.8

2.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

156

628

2.03

14.77

1.2

—

(3000991) Gas panel - Venous blood

989

6154

1.33

14.76

5.2

7.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

123

3.44

14.26

1.4

1.3

2.1

0.46

103

(40768443) Skin Pathology biopsy report

747

4480

1.37

14.22

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1866

12626

1.23

14.00

1.9

29.2

29.4

0.63

1810

12195

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

1254

1.69

13.93

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

242

3244

0.60

13.82

1.6

iu/ml

0.1

6.6

0.69

663

(3000850) Epithelial cells [#/volume] in Urine

2734

19223

1.19

13.67

2.2

2.5

e6/l

7.8

7.3

0.65

2366

16574

(40761536) Microorganisms panel - Urine sediment

1236

8006

1.28

13.63

4.2

4.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

430

2350

1.50

13.63

2.2

2.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

169

723

1.91

13.49

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

434

2385

1.49

13.40

1.8

2.0

96.2

96.6

0.12

383

2137

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1327

8690

1.26

13.36

2.2

u/l

48.8

36.3

0.98

1134

7293

(3013139) Helicobacter pylori Ag [Presence] in Stool

822

8692

0.75

13.31

1.2

—

(3012501) Base excess in Blood by calculation

339

1770

1.57

13.25

3.4

mmol/l

2.5

2.7

0.49

244

1255

(3013290) Carbon dioxide [Partial pressure] in Blood

339

1771

1.57

13.22

3.4

kpa

5.0

5.1

1.33

326

1729

(3016502) Oxygen saturation in Arterial blood

1189

7696

1.28

13.18

5.4

6.5

96.0

95.5

1.73

1142

7393

(3015171) Extractable nuclear Ab [Units/volume] in Serum

455

5253

0.69

12.84

1.2

1.3

u/ml

1.2

0.8

0.25

495

(3020682) Albumin/Creatinine [Ratio] in Urine

3478

31617

0.86

12.82

3.5

3.8

mg/mmol

6.0

6.8

0.37

1799

17856

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

116

3.36

12.79

1.2

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

339

1790

1.55

12.64

3.4

3.5

kpa

8.6

8.5

0.62

326

1748

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

197

905

1.78

12.58

1.4

1.3

—

(3025159) Blasts/100 leukocytes in Blood

1126

7284

1.27

12.54

3.0

4.0

0.6

0.1

0.81

390

1223

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

343

2.28

12.34

1.6

1.4

—

(3007461) Platelets [#/volume] in Blood

14387

115082

1.39

12.28

27.5

17.2

e9/l

258.7

264.3

23.89

14190

111704

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10614

89444

0.87

12.14

4.4

4.5

pmol/l

14.9

14.8

6.55

9511

82039

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

353

2.24

11.96

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

677

7238

0.75

11.84

1.2

1.3

u/ml

190.3

192.8

0.03

614

6701

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5091

44843

0.88

11.53

2.5

2.8

ug/l

142.1

94.4

18.14

4649

41403

(3035941) MCH [Entitic mass]

14387

115151

1.37

11.43

27.3

17.1

30.4

30.2

41.17

14293

113239

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12225

101874

0.85

11.42

5.3

mu/l

2.1

0.10

11056

94068

(44806118)

161

719

1.83

11.34

1.2

1.4

—

(44790048)

161

719

1.83

11.34

1.2

1.4

—

(44790049)

161

719

1.83

11.34

1.2

1.4

—

(44790047)

161

719

1.83

11.34

1.2

1.4

—

(3024731) MCV [Entitic volume]

14387

115161

1.37

11.31

27.4

17.2

91.9

91.1

111.46

14293

113246

(3012516) Albumin [Mass/volume] in Urine

3319

30048

0.87

11.27

2.8

3.1

mg/l

451.1

416.9

0.13

1728

16672

(3021387) Prolactin [Units/volume] in Serum or Plasma

146

2111

0.56

11.19

1.8

1.7

mu/l

327.1

337.1

0.08

135

1877

(40767503) Oxygen content in Capillary blood by calculation

317

1696

1.53

11.19

2.3

2.4

15.9

16.2

0.65

143

843

(3010813) Leukocytes [#/volume] in Blood

14388

115181

1.37

11.18

27.5

17.3

e9/l

6.2

6.5

8.01

14173

111434

(3026361) Erythrocytes [#/volume] in Blood

14387

115173

1.37

11.16

27.5

17.2

e12/l

4.3

4.4

250.42

14174

111425

(3024891) Influenza virus A+B Ag [Presence] in Specimen

395

2212

1.46

11.16

1.1

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7423

63825

0.89

11.14

2.6

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

990

1.69

11.04

1.4

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

14387

115200

1.36

10.84

27.6

17.3

g/l

129.8

133.3

239.03

14296

113311

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

396

2.10

10.77

1.6

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2769

25318

0.86

10.68

1.2

1.3

u/ml

1.4

1.5

0.13

633

6913

(3028271) Lactate [Moles/volume] in Capillary blood

250

1289

1.58

10.42

1.8

1.7

mmol/l

1.7

0.56

245

1263

(3009508) Creatinine [Moles/volume] in Urine

3470

31173

0.87

10.36

2.8

3.0

mmol/l

6.3

6.4

1.29

2785

26105

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

216

1079

1.63

10.26

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1549

10601

1.21

10.23

2.5

2.1

umol/l

8.8

6.2

3.71

1319

8885

(3003338) MCHC [Mass/volume]

10412

87560

0.88

10.19

24.1

15.2

g/l

330.0

330.6

13.58

10364

86944

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

392

2240

1.43

10.00

2.5

2.3

193.3

179.2

2.36

374

2089

(3025468) Yersinia sp identified in Specimen by Organism specific culture

244

1266

1.57

9.93

1.3

—

(4034850)

331

3857

0.69

9.90

11.3

8.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.87

9.82

1.4

1.3

9.6

11.7

0.28

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

620

3829

1.33

9.82

6.3

7.9

mmol/l

24.6

24.7

0.10

576

3518

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3184

23194

1.14

9.64

1.6

1.7

mg/l

1.2

1.0

3.92

2450

17676

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

243

1269

1.56

9.63

1.3

—

(3033799) Differential panel - Peritoneal fluid

148

2.75

9.58

1.2

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3817

28149

1.13

9.57

2.6

2.7

ng/l

1015.2

1105.6

0.74

3247

23666

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

336

3880

0.70

9.56

1.7

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

245

1285

1.56

9.53

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

243

1273

1.56

9.50

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

140

2.79

9.45

1.1

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

618

3841

1.32

9.37

6.8

8.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

243

1282

1.55

9.23

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

501

5385

0.75

9.13

1.1

titre

390.0

162.5

—

123

(3026493) Urate [Moles/volume] in Serum or Plasma

2836

25631

0.87

9.04

2.1

2.0

umol/l

5139.9

4350.5

0.42

2375

21861

(3036489) Thrombin time

517

3148

1.34

9.04

1.8

21.9

21.3

0.65

441

2655

(3042631) Mycobacterium sp identified in Specimen

192

964

1.62

9.00

2.2

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4581

40171

0.89

8.92

4.0

4.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

173

2.54

8.91

1.3

2.0

e6/l

2252.7

22261.3

0.87

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1570

10898

1.19

8.85

3.3

4.4

mmol/l

1.0

0.92

1433

9946

(3023487) Leukocytes [#/volume] in Peritoneal fluid

190

2.44

8.68

1.4

2.3

e6/l

793.2

1264.3

0.33

129

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

8.64

1.1

0.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

246

1325

1.51

8.53

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

150

2.60

8.35

1.7

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

138

651

1.73

8.22

2.2

2.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

210

1102

1.55

8.22

1.2

u/l

24.0

20.4

2.03

174

869

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

233

2790

0.67

8.13

1.3

miu/ml

252.5

220.7

0.65

108

1347

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

179

909

1.60

8.07

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

413

2480

1.36

7.96

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3655

32271

0.89

7.78

1.9

2.0

u/l

167.1

162.9

0.10

3373

29999

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

161

2.47

7.73

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1207

0.52

7.68

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

228

2.21

7.62

1.0

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1672

11811

1.17

7.60

2.1

2.5

21.6

22.2

1.00

1457

9935

(3009542) Hematocrit [Volume Fraction] of Blood

11761

92952

1.12

7.56

19.2

12.8

38.6

39.2

11.50

8306

66095

(3001019) Free T4 and TSH panel - Serum or Plasma

624

6354

0.79

7.55

1.7

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

962

0.48

7.33

1.3

1.5

—

3.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

571

5844

0.78

7.22

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

863

8440

0.82

7.19

1.2

iu/ml

170.7

153.1

0.61

345

3423

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.66

7.05

1.4

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

249

1401

1.45

7.04

2.0

2.7

umol/l

37.7

32.4

1.86

201

1200

(3044007) Cell count panel - Peritoneal fluid

154

2.43

7.01

1.3

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1194

11308

0.84

7.00

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1273

8862

1.18

6.93

2.0

2.2

1.9

1.8

2.12

1117

7674

(40761535) Cells panel - Urine sediment

883

8577

0.82

6.87

3.1

3.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1003

9627

0.83

6.86

1.5

1.6

1.4

0.64

864

8434

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.07

6.79

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1129

10713

0.84

6.77

1.4

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.79

6.75

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1697

12120

1.15

6.65

21.2

22.3

inr

1.3

0.12

250

1705

(3027944) Amphetamines [Presence] in Urine

141

1790

0.64

6.61

1.6

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

159

832

1.56

6.41

5.1

6.1

mg/l

12.7

12.1

0.73

143

747

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

151

2.37

6.39

3.3

1.2

ng/l

61.7

62.4

0.01

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1146

0.56

6.34

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

103

1386

0.60

6.23

1.6

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1788

12875

1.14

6.22

2.0

2.4

g/l

2.4

0.08

1637

11751

(1002224) Polysomnography panel

399

4182

0.77

6.16

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

400

1.79

6.08

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

400

1.79

6.08

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

819

0.49

5.98

1.4

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

149

1821

0.66

5.89

2.3

1.7

nmol/l

0.9

0.8

0.82

124

1498

(3016879) Cocaine [Presence] in Urine

133

1663

0.65

5.87

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

195

2.13

5.80

1.8

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

790

5362

1.21

5.75

1.3

—

(1616796) Gas panel - Central venous blood

280

1671

1.37

5.74

3.2

—

(3028300) Cannabinoids [Presence] in Urine

151

1829

0.67

5.72

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

352

3707

0.76

5.66

1.2

1.3

u/ml

9.2

45.3

7.39

237

(3027008) Opiates [Presence] in Urine

151

1823

0.67

5.63

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

151

1816

0.67

5.53

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

152

817

1.51

5.50

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

323

3425

0.76

5.48

1.5

1.8

g/l

0.2

1.19

297

3241

(3001964) Herpes simplex virus Ag [Presence] in Specimen

239

1.97

5.44

1.1

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

550

1.63

5.43

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

321

3402

0.76

5.43

1.2

1.3

u/ml

6.1

7.1

0.13

603

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

827

7905

0.84

5.43

2.4

au/ml

29.9

28.1

0.10

448

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

316

3355

0.76

5.42

1.2

1.3

u/ml

5.7

6.5

0.08

379

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

361

1.78

5.41

1.1

—

(4010399)

861

8199

0.84

5.41

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

443

4505

0.79

5.39

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

937

6503

1.18

5.34

2.2

e9/l

71.0

71.5

0.16

695

4889

(3003888) Timothy IgE Ab [Units/volume] in Serum

130

1595

0.66

5.29

1.1

u/ml

2.8

2.6

0.10

684

(3008401) Mugwort IgE Ab [Units/volume] in Serum

124

1536

0.65

5.28

1.1

u/ml

1.5

0.8

0.29

545

(3012544) pH of Venous blood

1106

7788

1.16

5.26

2.6

3.5

7.4

—

(3049717) Cytology report of Urine Cyto stain

352

2205

1.30

5.23

2.5

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

110

556

1.61

5.22

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

300

3183

0.76

5.14

1.1

u/ml

1.8

7.8

5.06

362

(3035637) Corticotropin [Mass/volume] in Plasma

163

904

1.47

5.10

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

9088

71428

1.08

5.07

4.3

4.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.28

5.03

1.2

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

160

1865

0.69

5.01

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

117

2.36

4.99

1.1

1.6

g/l

28.8

21.6

1.63

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

335

3488

0.77

4.98

1.5

1.8

g/l

1.2

0.46

308

3301

(3042111) Morphology [Interpretation] in Bone marrow Narrative

169

949

1.45

4.97

1.6

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

353

2229

1.29

4.96

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

538

3579

1.23

4.85

2.6

3.8

mmol/l

24.6

24.5

0.36

477

3170

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

287

3029

0.76

4.76

1.8

—

(3042733) HLA Ab [Presence] in Serum

222

0.26

4.75

4.7

5.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

223

0.25

4.75

1.3

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

261

2787

0.76

4.72

1.2

u/ml

26.0

47.8

2.72

313

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

593

0.48

4.72

1.2

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2347

20727

0.90

4.70

1.4

1.3

g/l

2.3

0.71

1141

12036

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

491

0.43

4.69

1.7

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

153

1774

0.70

4.68

1.1

u/ml

1.7

1.2

0.29

599

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

2.34

4.63

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

758

7194

0.85

4.61

1.2

1.3

au/ml

55.8

47.7

0.33

305

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1177

0.63

4.61

1.1

u/ml

1.6

3.1

1.61

422

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1026

0.61

4.59

1.1

1.0

u/ml

0.1

0.5

1.08

192

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

693

0.53

4.56

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

102

2.39

4.54

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

101

1261

0.65

4.53

1.0

1.1

u/ml

3.1

3.4

0.10

423

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

1417

0.67

4.53

1.1

u/ml

1.1

0.02

290

(3002032) Base excess in Venous blood by calculation

1053

7483

1.15

4.46

2.6

3.4

mmol/l

2.2

0.11

876

6226

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1055

7511

1.15

4.36

2.6

3.4

kpa

5.8

5.9

1.39

1020

7291

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

603

5806

0.84

4.36

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1040

9594

0.87

4.35

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

1619

11853

1.12

4.33

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1177

0.65

4.30

1.1

—

0.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

207

1239

1.36

4.28

2.5

5.0

iu/ml

1022.6

830.6

0.09

167

(3000492) Spirometry study

1050

9653

0.87

4.19

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

376

0.39

4.18

1.4

1.7

ug/l

9.1

8.6

0.26

376

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

317

1.72

4.17

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

317

1.72

4.17

1.2

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

555

0.50

4.16

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

648

0.54

4.10

1.3

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

584

0.51

4.10

1.1

1.0

u/ml

0.5

1.9

—

130

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

647

0.54

4.08

1.3

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

394

0.41

4.06

2.7

3.0

umol/l

26.8

27.7

0.12

301

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

646

0.54

4.06

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

646

0.54

4.06

1.3

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

1623

0.71

4.06

1.3

1.5

g/l

0.6

0.7

0.35

1227

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1062

0.64

4.04

1.5

33.1

34.1

0.09

619

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

108

2.26

4.04

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.45

4.01

1.3

1.2

mmol/l

2.9

2.2

0.11

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

111

1321

0.68

3.98

1.1

iu/ml

59.9

10011.6

0.57

246

(3028707) Methadone [Presence] in Urine by Screen method

857

0.60

3.96

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

937

0.62

3.95

1.3

u/ml

4.0

1.2

0.38

424

(3014891) Appearance of Pleural fluid

2.52

3.93

1.4

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

939

8658

0.87

3.93

1.7

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

221

1.84

3.92

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1910

14200

1.10

3.85

2.1

2.4

umol/l

12.8

13.2

1.08

1765

12941

(3011288) Drugs identified in Urine by Screen method

101

1215

0.67

3.84

2.3

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

819

0.60

3.83

1.3

1.2

titre

212.0

196.6

—

142

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

370

0.42

3.78

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

383

1.61

3.77

1.6

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

268

2761

0.78

3.76

1.2

u/ml

1.0

5.3

2.28

214

(3028433) Virus identified in Specimen by Culture

266

1.74

3.76

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

531

1.52

3.76

1.7

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

384

3797

0.82

3.72

1.6

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.88

3.69

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

208

1.84

3.69

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

852

6052

1.15

3.69

4.7

6.3

mmol/l

8.6

9.5

3.71

812

5730

(3005719) IgG [Mass/volume] in Serum or Plasma

760

7077

0.86

3.67

2.6

2.4

g/l

10.3

10.6

0.72

685

6439

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

878

8093

0.87

3.67

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

932

1.38

3.64

1.5

2.4

u/ml

8244.5

941.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

270

1721

1.28

3.64

1.4

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

194

2074

0.76

3.64

1.9

2.3

ug/min

41.1

62.6

0.80

1131

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

710

4982

1.16

3.63

2.6

3.2

kpa

5.2

0.06

642

4554

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

326

2127

1.25

3.62

2.1

2.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

1.86

3.61

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

776

0.60

3.61

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

601

0.55

3.61

1.1

1.0

u/ml

0.4

1.1

0.78

165

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

181

1.89

3.58

1.2

1.1

pmol/l

2.6

3.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

924

0.64

3.58

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

6155

51835

0.94

3.58

3.7

3.9

estimate

0.0

0.69

1232

8803

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

280

2845

0.79

3.52

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

574

0.55

3.49

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

367

1.59

3.44

2.4

2.2

—

(3046861) Legionella sp Ag [Presence] in Urine

3.36

3.33

1.3

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2928

25224

0.93

3.24

3.3

3.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

548

0.56

3.20

1.2

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

207

2152

0.78

3.19

1.3

1.4

e6/l

848.7

2476.6

1.75

153

1776

(3005033) Fetal Nuchal fold Thickness US

546

0.56

3.16

1.2

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

207

2149

0.78

3.16

1.3

1.4

e6/l

13.0

37.7

2.13

141

1684

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

336

3304

0.82

3.14

1.5

1.6

titre

87.7

312.1

5.49

186

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

113

1278

0.72

3.13

1.2

u/l

31.1

23.7

0.51

1108

(3009343) pH of Capillary blood

693

4914

1.15

3.12

2.6

3.2

7.4

1.51

111

616

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

253

1635

1.26

3.11

1.5

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2697

23265

0.93

3.08

1.6

1.7

pmol/l

37722223.9

37625663.8

0.00

2142

19168

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

130

1432

0.73

3.06

1.5

1.6

54.5

53.2

0.14

876

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

506

3513

1.17

3.02

4.4

4.1

1.5

1.6

5.98

480

3303

(3008152) Bicarbonate [Moles/volume] in Arterial blood

708

5042

1.15

3.01

5.5

6.3

mmol/l

25.3

24.9

2.31

660

4667

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

778

0.65

2.99

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

936

8470

0.89

2.97

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

774

0.65

2.93

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

875

6331

1.13

2.93

2.4

2.9

kpa

4.4

4.5

0.29

840

6139

(3007930) Methemoglobin/Hemoglobin.total in Blood

497

3456

1.17

2.92

4.5

4.2

0.9

0.37

469

3246

(3004616) Nuclear Ab [Presence] in Serum

149

1595

0.76

2.91

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

665

4734

1.15

2.86

2.6

3.1

mmol/l

2.2

2.1

0.36

528

3603

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.29

2.85

2.7

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

366

1.53

2.85

2.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

115

1.98

2.80

1.3

1.2

mmol/l

2.3

1.8

1.36

(3039162) Centromere protein B Ab [Units/volume] in Serum

161

1696

0.77

2.80

1.2

1.3

u/ml

75.0

58.6

—

130

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

178

0.36

2.69

2.1

1.9

umol/l

13.5

18.3

—

178

(3004716) Salmonella sp identified in Stool by Organism specific culture

584

5407

0.87

2.69

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

153

1612

0.77

2.68

1.1

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

418

1.48

2.67

1.7

1.9

71.7

74.1

0.65

399

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

189

1.72

2.63

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

129

1386

0.75

2.62

5.3

5.2

umol/l

362.3

379.7

0.67

109

1213

(3034770) Mitochondria Ab [Titer] in Serum

309

3003

0.83

2.62

1.2

titre

635.7

1046.8

1.14

145

(4094501)

314

3044

0.83

2.59

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1056

0.72

2.57

1.2

1.4

g/l

0.4

0.13

757

(3027135) IgG subclass 1 [Mass/volume] in Serum

1056

0.72

2.57

1.2

1.4

g/l

6.8

6.7

0.05

754

(3028192) IgG subclass 2 [Mass/volume] in Serum

1055

0.72

2.56

1.2

1.4

g/l

2.8

2.9

0.39

753

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2475

18931

1.07

2.56

3.3

3.5

ng/l

119.0

309.5

8.33

1909

13762

(3000330) Specific gravity of Urine by Test strip

591

5445

0.88

2.55

4.1

3.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

995

0.72

2.51

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

278

2715

0.83

2.50

1.6

e6/l

17270.5

10900.7

1.00

197

1978

(3014051) Protein [Presence] in Urine by Test strip

269

2634

0.83

2.49

2.3

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

156

1619

0.78

2.46

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

856

6258

1.12

2.45

2.1

1.5

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

2.45

0.0

1.2

—

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

449

4204

0.86

2.45

1.4

1.5

u/ml

26.6

15.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1018

0.72

2.45

1.4

e6/l

229640.8

104752.3

0.71

684

(4062490)

1055

0.73

2.44

1.2

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1055

0.73

2.44

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

242

0.44

2.43

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.08

2.43

1.3

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

441

1.44

2.42

1.1

101.5

97.1

0.82

337

(3028626) Oxygen [Partial pressure] in Capillary blood

243

1616

1.22

2.40

2.4

2.6

kpa

8.3

8.2

0.32

222

1503

(3047007) Chlamydophila sp Ab [Presence] in Serum

154

1594

0.78

2.39

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

6239

52116

0.95

2.39

5.0

5.2

estimate

0.0

3.28

1234

8887

(3028026) IgM [Mass/volume] in Serum or Plasma

607

5557

0.88

2.39

1.9

1.5

g/l

1.3

0.01

539

5053

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

280

1889

1.21

2.39

2.7

2.8

mg/l

1.4

1.5

2.26

248

1710

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.63

2.29

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

644

0.67

2.28

1.6

1.4

u/l

6.0

5.2

0.53

539

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

407

1.44

2.26

1.7

1.8

12.0

14.7

1.43

204

(3014271) Vancomycin [Susceptibility]

468

1.41

2.25

2.6

3.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

398

2789

1.16

2.21

1.9

1.4

g/l

38.1

37.9

0.18

318

2323

(3011412) CD3 cells [#/volume] in Blood

567

1.36

2.19

2.0

2.1

e9/l

1.3

0.09

302

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3603

30474

0.95

2.19

1.6

1.7

mmol/l

1.4

1.3

0.70

2957

25562

(3027456) Digoxin [Moles/volume] in Serum or Plasma

282

1925

1.19

2.16

3.2

3.3

nmol/l

0.8

1.40

219

1531

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

127

1.79

2.16

1.0

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

420

2962

1.15

2.15

2.0

1.5

g/l

0.7

0.4

0.64

348

2499

(3029937) Albumin [Presence] in Urine by Test strip

3280

27803

0.95

2.15

4.1

4.4

estimate

0.0

2.76

1232

8957

(3009261) Glucose [Presence] in Urine by Test strip

6312

52615

0.95

2.15

3.7

3.9

estimate

0.0

0.23

1245

8911

(3012494) Peanut IgE Ab [Units/volume] in Serum

294

0.52

2.14

1.1

1.0

u/ml

0.5

0.8

—

144

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

155

1578

0.79

2.13

1.3

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

290

1988

1.19

2.12

2.0

2.1

g/l

125.8

128.4

1.18

198

1426

(3052592) Norovirus Ag [Presence] in Stool

165

1.67

2.09

1.5

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

130

1345

0.78

2.06

1.2

mmol/l

7.5

7.4

0.11

109

978

(3021901) Oxygen saturation in Capillary blood

208

1387

1.22

2.05

2.5

2.7

—

(3047181) Lactate [Moles/volume] in Blood

366

2566

1.16

2.05

5.1

4.8

mmol/l

1.3

0.10

327

2262

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

882

7831

0.91

2.04

2.0

2.3

ug/l

3.8

5.9

8.79

725

6675

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

213

0.46

2.03

1.3

1.1

—

(3022313) Gas panel - Capillary blood

494

3543

1.14

2.01

2.6

3.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

439

3126

1.14

1.99

2.7

3.3

mmol/l

25.4

25.2

0.55

394

2844

(3007566) Smooth muscle Ab [Titer] in Serum

314

2965

0.86

1.98

1.2

titre

113.9

143.1

0.25

255

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

348

0.58

1.98

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

962

0.75

1.98

2.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.98

1.97

1.1

2.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3082

23933

1.06

1.96

1.5

nmol/l

21.7

21.9

0.22

2537

20096

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

392

1.41

1.96

1.1

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

295

0.55

1.95

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

295

0.55

1.95

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

295

0.55

1.95

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

295

0.55

1.95

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

437

0.63

1.95

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.89

1.94

1.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

991

7399

1.09

1.93

3.3

2.6

e9/l

3.8

3.9

0.47

791

5605

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

128

0.38

1.91

1.3

1.1

—

(3000012) Reticulocyte production index

456

1.37

1.91

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

503

0.66

1.91

1.1

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.03

1.89

1.3

1.2

u/l

33.3

603.0

0.51

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

217

0.49

1.88

1.4

1.2

—

(3019977) pH of Arterial blood

423

1.38

1.88

2.8

2.7

7.4

0.64

140

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.75

1.87

1.2

1.0

—

(4198724)

227

0.50

1.86

1.1

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.06

1.86

1.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

438

1.37

1.85

1.9

37.3

47.3

2.31

(3039000) Anion gap in Blood

253

1740

1.18

1.83

6.1

5.6

mmol/l

10.7

11.1

1.55

227

1563

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2060

17618

0.94

1.83

1.4

—

(3018572) Chloride [Moles/volume] in Blood

253

1741

1.18

1.82

6.1

5.6

mmol/l

105.4

104.7

1.67

227

1564

(3021788) Differential panel - Synovial fluid

212

2049

0.84

1.80

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

171

1686

0.82

1.80

1.4

1.6

—

(3004775) Volume in Urine collected for unspecified duration

675

0.72

1.77

1.6

2.3

654.7

633.7

0.16

487

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

204

1382

1.20

1.76

1.1

125.2

124.9

0.04

186

1233

(3015235) Bicarbonate [Moles/volume] in Capillary blood

279

1944

1.17

1.74

2.5

2.8

mmol/l

25.8

25.3

0.92

237

1707

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.79

1.73

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

403

0.64

1.72

1.1

miu/ml

1039.0

1568.6

2.55

403

(3019060) Gas panel - Arterial blood

708

5238

1.10

1.71

4.1

4.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

604

0.71

1.70

1.1

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

463

3349

1.13

1.70

1.9

1.4

g/l

3.2

3.1

2.03

347

2538

(3026692) Albumin [Mass/volume] in Peritoneal fluid

144

1.64

1.69

1.1

1.4

g/l

14.3

10.6

1.47

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

798

0.75

1.67

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3257

27433

0.95

1.65

3.7

3.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

142

935

1.23

1.65

3.6

7.4

mmol/l

7.0

7.6

1.08

118

762

(3008536) Aspergillus sp Ab [Presence] in Serum

114

1.71

1.64

2.0

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

477

3467

1.12

1.62

1.4

1.6

g/l

1.7

1.6

1.22

385

2953

(3034274) Bile acid [Moles/volume] in Serum --fasting

673

0.73

1.62

1.3

1.6

umol/l

7.2

8.0

0.09

478

(3016750) Collection duration of Urine

503

0.69

1.61

1.5

2.2

min

519.2

500.4

0.59

395

(3006653) Thiamine [Moles/volume] in Blood

474

0.68

1.61

1.2

1.4

nmol/l

126.5

132.9

0.58

474

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

366

2620

1.14

1.60

2.0

1.4

g/l

0.0

0.34

322

2371

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

115

1.69

1.60

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

140

0.46

1.60

17.9

8.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2834

22084

1.05

1.58

3.7

4.1

—

(3047189) Immunofixation for 24 hour Urine

232

1.47

1.57

2.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

339

2419

1.14

1.56

2.0

1.4

g/l

0.0

0.35

296

2178

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.96

1.56

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

116

1.68

1.56

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

116

1.68

1.56

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

630

0.73

1.54

2.2

2.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

104

1.72

1.54

1.0

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

583

0.72

1.54

1.2

1.5

2.7

4.6

0.95

113

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

795

0.76

1.53

1.0

ng/l

38.5

47.3

1.18

558

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

227

1.47

1.52

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

117

1.67

1.52

6.6

1.3

u/l

44.1

42.2

—

(3022621) pH of Urine by Test strip

843

7385

0.92

1.51

3.4

3.1

—

(3037121) Protein [Mass/volume] in Urine

401

2901

1.12

1.50

2.4

2.5

g/l

0.2

0.3

4.31

127

762

(44816559) Phosphatidylethanol [Mass/volume] in Blood

149

1457

0.83

1.50

1.2

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

334

2390

1.14

1.49

2.0

1.4

g/l

0.0

0.00

296

2170

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

235

1.45

1.49

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

343

3140

0.88

1.47

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

643

0.74

1.47

2.1

ug/l

4.2

0.02

572

(40757373) Influenza virus identified in Isolate

150

1.57

1.47

1.2

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

790

0.77

1.47

1.0

ng/l

731.1

734.1

0.02

541

(3024932) HLA-DR beta [Type]

208

0.55

1.47

1.4

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.96

1.46

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.96

1.46

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

479

1.31

1.45

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

318

0.64

1.45

1.5

1.4

41.5

50.2

0.49

271

(3025577) Chromium [Mass/volume] in Blood

622

0.74

1.44

2.0

2.1

ug/l

3.0

2.9

0.03

522

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

243

2270

0.87

1.42

1.2

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

369

2668

1.13

1.41

3.0

1.6

mg/l

36.3

34.5

0.08

290

2162

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.13

1.40

6.9

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

604

1.26

1.40

1.1

ratio

1.0

1.1

1.84

218

(3013707) Erythrocyte sedimentation rate by Westergren method

9898

81321

0.96

1.40

3.7

4.3

mm/h

14.2

12.3

28.03

9008

75446

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

383

0.68

1.40

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

783

0.78

1.39

1.0

ng/l

322.2

348.1

0.39

560

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

239

1.43

1.38

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

211

1986

0.86

1.38

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1783

13784

1.06

1.37

4.4

4.7

33.5

33.3

0.32

1129

9304

(3037756) Immunofixation for Serum or Plasma

232

1631

1.16

1.36

1.8

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4086

32209

1.04

1.36

2.3

2.2

u/l

57.3

58.1

0.29

3741

29310

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

316

2889

0.88

1.36

1.1

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

428

0.70

1.35

9.4

11.0

nmol/l

702.2

3147.0

0.53

412

(3024263) Appearance of Synovial fluid

549

0.74

1.34

1.4

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

301

0.65

1.33

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

159

0.51

1.32

1.8

1.3

—

(3024471) HLA-A [Type]

211

0.58

1.32

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

117

777

1.22

1.32

2.2

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

369

2682

1.12

1.32

3.0

1.6

mg/l

47.1

38.7

0.31

292

2181

(21494434) Karyotype in Bone marrow

581

1.26

1.31

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4845

38343

1.04

1.30

3.3

ng/l

29.8

51.5

1.68

3429

23914

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.90

1.30

1.0

1.1

2.2

1.7

—

(40768446) Kidney Pathology biopsy report

269

0.63

1.28

1.3

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

100

656

1.24

1.27

1.5

1.6

mmol/24h

5.8

5.5

0.11

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

129

0.50

1.26

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

449

3308

1.10

1.26

1.9

1.4

g/l

9.8

10.1

0.57

359

2710

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

264

2425

0.88

1.25

1.3

mg/l

538.5

528.1

0.10

250

2298

(44813793)

896

0.80

1.24

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

102

1012

0.82

1.24

1.1

—

47.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

131

1.55

1.23

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

586

0.76

1.22

1.2

1.5

promille

1.4

1.2

0.41

428

(3011897) Casein IgE Ab [Units/volume] in Serum

154

0.53

1.22

1.0

1.1

—

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

580

1.25

1.21

1.7

1.6

—

(4027681)

519

0.75

1.19

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

247

1.38

1.19

2.0

2.5

40.2

46.7

0.59

(3045716) Anion gap in Serum or Plasma

402

1.29

1.18

2.2

2.6

mmol/l

9.8

8.9

1.34

292

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

1.18

0.0

1.0

—

0.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

102

1005

0.82

1.17

1.2

u/ml

19.8

50.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

490

0.74

1.17

1.5

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

143

1366

0.85

1.17

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

3548

1.10

1.17

2.0

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

133

1278

0.84

1.17

1.1

1.2

u/ml

266.9

294.3

0.43

837

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

1.17

0.0

1.0

—

0.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

1004

0.82

1.16

1.2

u/ml

107.3

71.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

292

2651

0.89

1.16

1.2

1.5

iu/ml

9.5

21.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

354

2590

1.11

1.16

3.0

1.5

ratio

3.9

1.5

0.47

218

(3000093) Morphology [Interpretation] in Blood Narrative

102

679

1.22

1.16

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

193

1359

1.15

1.16

2.2

2.0

mg/l

27.8

24.5

0.32

352

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.94

1.14

1.1

mg/l

11.5

13.0

0.13

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

477

3547

1.09

1.13

2.0

1.4

g/l

3.8

3.7

0.36

336

2477

(3022475) Manganese [Moles/volume] in Blood

1.82

1.13

1.6

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

3555

1.09

1.13

2.0

1.4

g/l

7.7

7.5

1.26

360

2579

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

496

0.75

1.13

1.0

1.1

u/l

1.0

1.1

0.84

224

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

505

0.75

1.13

12.3

12.4

mmol/l

0.7

0.6

0.90

456

(3048879) Bone marrow aspiration report

188

1.43

1.12

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

162

1525

0.86

1.12

1.0

1.1

u/ml

2.0

3.2

1.15

698

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

230

0.63

1.12

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.27

1.10

11.9

1.0

—

(3024928) Oxygen saturation in Venous blood

233

1670

1.13

1.10

1.9

3.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.71

1.09

2.8

1.6

—

(44806071)

134

0.54

1.09

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

456

0.75

1.09

12.1

15.4

nmol/l

1269.4

4869.7

0.54

437

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

951

0.83

1.08

1.2

u/ml

1.9

9.7

—

(3045424) Erythrocytes [Presence] in Urine

262

1894

1.12

1.08

1.4

1.6

—

(3045414) Leukocytes [Presence] in Urine

598

5219

0.93

1.06

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.76

1.03

1.2

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

301

0.70

1.02

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

591

4461

1.08

1.01

2.4

e6/l

0.3

0.37

571

4263

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

486

0.77

1.01

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

186

1.40

1.00

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

108

0.53

1.00

4.0

7.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

153

1430

0.87

0.99

1.4

1.2

nmol/l

—

(3022145) Colonoscopy Study observation

1478

11483

1.05

0.99

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.98

0.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

429

0.76

0.98

1.4

nmol/l

2.0

1.2

0.36

340

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

237

2150

0.89

0.97

1.2

mmol/l

3.6

3.7

1.11

223

2016

(3043410) Blood group antigens tested for on Red Blood Cells

194

1.38

0.97

1.5

1.6

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.83

0.97

1.0

1.2

u/l

411.2

391.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.96

0.96

1.0

1.2

—

(3034426) Prothrombin time (PT)

315

1.29

0.95

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

209

1.36

0.95

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

705

6086

0.94

2.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

181

1292

1.14

0.94

1.2

1.3

—

34.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

366

1.26

0.93

2.4

2.3

—

(4015189)

276

0.71

0.92

1.9

2.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

513

1.22

0.92

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

179

0.63

0.91

1.0

1.2

—

236.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

114

1080

0.86

0.91

1.4

—

(3025130) Human papilloma virus identified in Specimen

253

1849

1.11

0.90

1.4

1.7

—

(3044941) Cell count panel - Synovial fluid

189

1728

0.89

0.90

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

149

0.60

0.90

1.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

156

1107

1.14

0.90

2.4

2.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

246

0.69

0.90

1.2

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

276

2028

1.11

0.89

3.2

3.0

mmol/l

1.5

0.32

271

1987

(3051101) Glucose [Moles/volume] in Cord blood

188

0.65

0.89

4.9

5.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.60

0.89

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

700

0.82

0.89

1.2

mg/l

45.3

38.1

0.28

584

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8347

66926

1.03

0.88

2.9

u/l

54.7

40.2

20.32

7701

61945

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

107

0.53

0.88

1.1

1.4

—

149.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

357

3152

0.92

0.88

1.7

1.9

iu/l

28.8

15.9

0.22

136

1211

(3020891) Body temperature

443

3330

1.08

0.88

3.4

4.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.80

0.87

2.2

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

157

1118

1.14

0.87

2.4

2.2

mmol/l

105.0

105.8

1.31

157

1113

(4133840)

225

0.68

0.87

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

114

793

1.17

0.87

3.6

3.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

839

0.84

0.86

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

671

0.82

0.86

1.2

1.1

mg/l

321.0

247.6

0.62

586

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

528

0.80

0.86

1.8

1.9

—

(3041354) Potassium [Moles/volume] in Venous blood

157

1119

1.14

0.86

2.4

2.2

mmol/l

4.0

0.18

157

1114

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

243

0.70

0.85

1.2

1.3

mg/l

0.8

19.9

0.50

183

(40760888) Immunoglobulin light chains.free panel - Serum

265

1950

1.10

0.85

3.2

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.95

0.84

1.0

nmol/l

318.3

356.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

390

0.77

0.83

1.2

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

101

699

1.17

0.83

2.0

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.87

0.81

2.7

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

521

3957

1.07

0.80

2.1

2.6

0.6

0.7

0.29

501

3767

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

611

4666

1.07

0.80

1.1

u/ml

1.2

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

147

1352

0.88

0.80

1.1

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

611

5263

0.94

0.80

1.2

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

954

0.86

0.80

1.1

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.80

0.0

1.4

—

4.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.80

0.0

3.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

678

5195

1.06

0.80

2.5

3.1

g/l

124.7

128.6

5.34

657

5074

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

953

0.86

0.79

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

101

953

0.86

0.79

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

181

1.35

0.79

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

112

1.45

0.79

1.1

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.2

—

(3009871) Measles virus Ab [Titer] in Serum

368

0.77

0.79

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

238

1.30

0.78

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

513

4439

0.94

0.78

1.9

2.1

u/l

41.9

40.2

1.12

456

3957

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1104

9348

0.95

0.78

2.2

1.8

nmol/l

384.4

367.3

1.82

1005

8480

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

369

1.23

0.77

2.3

2.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

186

1681

0.90

0.77

1.1

au/ml

5.8

13.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

370

2781

1.08

0.77

1.9

2.1

ug/l

314.3

549.6

1.40

333

2575

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

284

0.74

0.77

1.5

2.3

ug/l

2.5

1.1

1.12

273

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

228

0.71

0.76

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

229

1685

1.10

0.76

1.8

1.7

u/l

846.3

2889.4

1.89

623

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.70

0.75

4.4

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

948

0.86

0.75

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

948

0.86

0.75

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

144

1033

1.13

0.75

1.2

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

946

0.87

0.74

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.73

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

648

0.84

0.72

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

778

0.85

0.71

1.1

1.0

mg/l

319.9

683.1

0.46

692

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

100

703

1.16

0.70

1.2

1.3

mmol/l

2.1

2.2

0.12

652

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

180

1619

0.90

0.70

1.4

1.2

nmol/l

0.2

0.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

415

0.80

0.70

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

137

1251

0.89

0.70

1.0

1.1

g/l

1.6

1.5

2.27

123

1114

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

242

0.74

0.69

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

714

6089

0.95

0.69

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

323

2824

0.93

0.68

2.0

2.2

mg/l

10.2

10.8

0.76

297

2605

(3045683) HLA typing for celiac disease panel - Blood or Tissue

652

0.85

0.68

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

116

1.40

0.68

1.3

ng/l

134.3

73.2

0.53

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.84

0.67

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

137

0.65

0.67

12.4

8.5

—

(3022689) Creatine [Moles/volume] in Urine

340

0.79

0.66

1.3

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

525

4023

1.06

0.66

2.2

2.7

1.1

1.2

3.34

525

4003

(40768797) Stomach Pathology biopsy report

1902

15870

0.97

0.66

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

107

0.61

0.64

1.0

—

(4306422)

196

1448

1.10

0.64

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.51

0.63

1.1

u/l

6.8

11.9

0.64

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

105

966

0.88

0.62

1.2

1.1

—

71.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2893

23969

0.97

0.62

2.2

2.3

mg/l

3.0

0.36

2452

20457

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

758

0.87

0.62

1.5

1.3

nmol/l

1.6

1.5

0.39

678

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

134

1213

0.90

0.61

1.2

1.4

u/ml

119.6

122.1

0.15

286

(3000060) B lymphocytes [#/volume] in Blood

162

0.70

0.61

1.4

2.0

e6/l

3608.3

145.1

—

104

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.61

0.0

1.1

—

(3036603) Volume of Urine

637

1.15

0.61

1.4

1.5

2238.4

1877.3

1.14

149

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.59

0.60

1.7

2.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

28.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

617

0.85

0.60

1.3

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

5.0

—

0.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

323

1.21

0.59

1.2

1.1

91.5

95.7

0.29

146

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

405

0.82

0.59

1.5

2.0

umol/l

224.8

132.7

0.43

223

(3006922) Hepatitis E virus Ab [Presence] in Serum

650

0.86

0.58

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

182

1616

0.91

0.58

1.4

1.2

nmol/l

5.2

1.6

0.36

176

1549

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

213

1.26

0.58

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

484

0.84

0.58

1.2

1.5

nmol/l

1.5

1.3

0.88

389

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.74

0.58

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

331

1.20

0.58

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

623

0.86

0.58

1.1

nmol/l

1.4

4.8

—

119

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

727

0.87

0.58

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1.24

0.57

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.68

0.57

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

143

1281

0.90

0.56

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

140

0.70

0.56

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

498

1.16

0.56

1.3

1.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

324

2463

1.07

0.55

3.0

4.0

mmol/l

3.8

0.39

306

2335

(3013466) aPTT in Blood by Coagulation assay

1.51

0.55

1.0

1.1

35.2

37.2

0.64

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

533

0.85

0.55

1.1

1.2

—

(4211845)

567

1.15

0.55

4.3

3.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

446

1.16

0.55

1.5

1.4

pmol/l

14.9

15.1

0.14

377

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

108

980

0.89

0.54

1.2

1.1

—

8.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

334

1.19

0.54

1.2

1.1

113.4

117.2

0.33

299

(3020650) Glucose [Presence] in Urine

245

1.23

0.54

1.4

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

216

1.24

0.53

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.46

0.53

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

187

1.26

0.53

1.2

1.1

78.6

93.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

284

0.80

0.53

2.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1625

13532

0.97

0.53

6.8

6.1

—

(3000285) Sodium [Moles/volume] in Blood

144

1.30

0.52

1.2

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

0.60

0.52

1.0

—

(3020491) Glucose [Moles/volume] in Blood

692

1.13

0.52

1.7

1.8

mmol/l

7.0

6.8

0.32

466

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

292

0.81

0.51

1.7

2.5

nmol/l

197.5

162.5

1.13

258

(3051593) INR in Capillary blood by Coagulation assay

412

1.16

0.50

7.7

9.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

375

1.17

0.49

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

136

0.72

0.49

1.2

1.1

umol/24h

1.7

1.6

0.18

136

(4146454)

125

1117

0.91

0.49

2.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

151

1337

0.92

0.49

1.1

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

145

0.73

0.48

1.7

1.5

53.7

45.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

399

1.16

0.48

1.1

ng/l

501.6

587.8

0.07

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

513

1.14

0.48

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5403

44325

0.98

0.47

1.9

2.0

pmol/l

100.1

100.4

0.12

2471

20426

(3027273) Bicarbonate [Moles/volume] in Venous blood

538

4177

1.05

0.47

2.7

3.0

mmol/l

25.9

25.7

0.72

528

4060

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

332

1.17

0.47

1.1

90.9

93.3

0.20

145

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.68

0.46

1.1

2.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.61

0.46

1.0

u/ml

0.0

0.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.48

0.46

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

170

1492

0.92

0.46

1.4

mu/l

31.9

50.1

1.85

149

1340

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.34

0.46

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

287

0.82

0.45

1.1

umol/24h

0.5

0.6

1.97

136

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

453

0.86

0.45

1.2

54.0

57.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

311

1.17

0.45

1.1

3.5

mg/l

8041.1

64.6

0.80

203

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

197

0.78

0.44

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.39

0.44

1.3

1.1

—

(3016038) Potassium [Moles/volume] in Urine

717

1.11

0.44

1.2

1.1

mmol/l

32.7

32.6

0.02

585

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

571

1.12

0.44

2.1

1.9

u/field

2.3

2.0

0.19

376

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.39

0.42

1.3

1.2

ug/l

92.0

130.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

174

1311

1.08

0.42

1.1

—

(3002619) Bacteria identified in Specimen by Culture

204

0.80

0.42

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

134.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.41

0.0

6.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.41

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

370

3151

0.95

0.41

1.4

ug/g

278.7

296.2

0.94

230

1761

(3002523) Influenza virus A Ag [Presence] in Specimen

174

1313

1.08

0.41

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2372

19576

0.98

0.40

1.7

nmol/l

1159.6

1201.2

1.28

1700

14682

(3036670) Protein [Mass/volume] in Synovial fluid

317

0.84

0.40

1.5

1.3

g/l

37.8

38.2

0.06

166

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.45

0.40

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.45

0.40

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

240

1.18

0.39

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.66

0.39

1.1

1.2

—

101.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

248

1.18

0.39

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

157

0.77

0.39

11.6

8.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

847

0.91

0.39

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

170

1477

0.93

0.38

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

120

0.74

0.38

1.1

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

191

1453

1.07

0.37

1.2

u/ml

2.9

3.5

0.24

487

(3006462) Nitrate [Presence] in Urine

524

1.12

0.37

4.5

3.2

—

(3017509) Phencyclidine [Presence] in Urine

0.65

0.36

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.63

0.36

5.4

6.4

—

(3025315) Body weight

0.62

0.36

4.0

4.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

0.72

0.35

3.4

5.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.32

0.35

1.9

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

109

0.74

0.34

1.2

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

404

1.13

0.34

1.1

iu/ml

—

3.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

0.78

0.34

2.0

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

134

1011

1.08

0.34

1.1

99.4

94.8

1.13

127

948

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

454

3823

0.96

0.34

1.7

mg/l

2.4

3.2

2.05

365

2741

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.69

0.33

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

121

912

1.08

0.32

1.2

1.4

mosm/kgh2o

273.0

275.2

0.49

693

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

740

1.09

0.32

1.2

1.3

titre

1024.0

479.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.28

0.32

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

233

1989

0.95

0.32

1.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

192

1472

1.06

0.32

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

133

1.22

0.32

1.8

2.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

330

1.13

0.32

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

110

962

0.93

0.32

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

384

1.12

0.31

1.2

g/l

0.3

0.64

313

(3006576) Bicarbonate [Moles/volume] in Blood

231

1.16

0.31

4.2

5.8

mmol/l

24.3

25.6

1.23

214

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

120

906

1.08

0.31

1.3

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

125

0.78

0.31

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

590

0.91

0.31

1.1

—

(36660697) Celiac disease serology panel - Serum

1095

9078

0.98

0.31

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

179

1.18

0.30

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

427

0.89

0.30

2.2

2.1

e9/l

0.2

0.16

373

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

106

0.77

0.29

1.2

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.72

0.29

1.0

1.1

—

2.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.33

0.29

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

132

0.80

0.28

1.2

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

226

1.15

0.28

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

723

1.08

0.28

1.2

1.3

titre

30.0

56.5

2.08

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

331

0.88

0.28

1.9

2.2

umol/l

40.7

54.8

2.51

254

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.28

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.77

0.27

11.6

11.5

mmol/l

4.4

—

(3028717) Thiamine [Mass/volume] in Blood

0.75

0.27

1.1

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.75

0.27

1.0

mmol/l

8.8

8.4

—

(40762814) Titanium [Mass/volume] in Blood

210

0.85

0.27

2.0

2.3

ug/l

4.8

3.9

0.24

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

585

0.91

0.27

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

412

1.10

0.27

2.0

2.1

ug/min

17.2

38.5

0.77

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

584

0.92

0.26

1.2

1.3

mmol/l

5.9

5.8

0.27

548

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

475

1.09

0.26

1.3

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.70

0.26

1.0

u/ml

0.0

0.3

—

(3004451) EKG impression Narrative

406

1.10

0.25

1.2

1.3

—

(44806420)

277

0.88

0.25

2.0

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

162

1381

0.95

0.24

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

176

1.15

0.24

1.0

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

409

1.09

0.23

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1008

8034

1.02

0.23

2.4

2.7

ng/l

163.2

171.7

0.35

919

7320

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.27

0.22

1.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

378

1.09

0.22

3.7

4.2

—

(3003181) Sodium [Moles/volume] in Urine

239

1866

1.04

0.22

1.4

mmol/l

56.2

62.1

1.63

186

1488

(4268621)

124

953

1.06

0.22

2.3

2.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

110

0.81

0.22

1.2

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

17.7

—

(3009677) Dengue virus Ab [Presence] in Serum

1.19

0.21

1.6

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

163

1383

0.96

0.21

1.4

1.3

pmol/l

269.0

284.4

0.32

130

1087

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.79

0.21

1.3

1.2

—

(3001729) Color of Synovial fluid

0.78

0.21

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

0.75

0.21

1.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

419

1.08

0.21

2.0

2.3

e6/l

502.3

1026.6

1.58

210

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.21

0.20

1.8

2.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

412

1.08

0.20

1.5

1.6

ug/l

0.4

0.34

264

(3032057) Clostridioides difficile [Presence] in Stool

225

1.12

0.20

1.7

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

148

1.15

0.20

4.0

5.8

70.9

69.4

0.09

114

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

741

0.94

0.20

1.2

1.3

mmol/l

10.9

11.7

0.39

172

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

271

0.90

0.19

1.1

1.2

pmol/l

230.0

322.3

1.29

190

(3017704) Immunofixation for Urine

429

1.08

0.19

1.8

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

219

0.89

0.18

1.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

396

0.92

0.18

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

696

0.94

0.18

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

579

0.94

0.17

1.4

1.3

—

(3023410) Appearance of Cerebral spinal fluid

114

968

0.96

0.17

1.3

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.72

0.17

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

493

0.94

0.16

1.4

1.7

nmol/l

2.3

3.7

1.14

401

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.76

0.15

1.8

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

355

1.07

0.15

1.2

111.4

114.2

0.28

307

(4024509)

158

1239

1.03

0.14

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

111

938

0.96

0.14

2.6

2.8

mg/l

73.0

35.4

0.37

621

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

265

0.92

0.14

2.6

2.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.85

0.13

1.8

1.7

umol/l

38.9

48.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

769

0.96

0.12

1.1

iu/ml

7.9

8.8

0.15

169

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

503

0.95

0.11

1.3

1.8

111.1

100.9

1.26

458

(3026389) Candida sp identified in Specimen by Organism specific culture

222

1842

0.98

0.11

1.3

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.87

0.10

2.5

2.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.09

1.1

—

(3023419) Bacteria identified in Sputum by Culture

130

1082

0.97

0.09

2.4

2.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.08

0.09

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

171

1417

0.98

0.08

1.2

u/ml

3.9

3.7

0.06

586

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

951

7657

1.01

0.08

3.1

3.0

pmol/l

4.5

4.4

0.54

844

6684

(3019420) Tryptase [Mass/volume] in Serum or Plasma

509

1.04

0.08

1.3

1.5

ug/l

7.3

8.9

0.47

447

(3035933) Granulocytes/100 leukocytes in Blood

198

1.07

0.07

3.3

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

0.82

0.07

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

135

1.08

0.07

2.1

2.3

—

(4212803)

1.04

0.07

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

149

0.93

0.07

1.3

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

124

0.92

0.07

1.1

1.3

mmol/l

7.4

5.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

384

3149

0.99

0.06

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

207

1.06

0.06

1.9

2.5

mmol/l

6.0

7.0

2.07

128

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

519

0.97

0.06

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

132

0.92

0.06

1.6

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

380

3115

0.99

0.06

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

269

2210

0.99

0.06

3.8

3.5

mg/l

22.6

0.01

147

1401

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

105

866

0.98

0.04

1.2

1.5

u/ml

30.6

22.6

0.44

182

(1761482) Bacteria [#/volume] in Urine by Culture

315

2574

0.99

0.03

5.4

4.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

385

3143

0.99

0.03

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

162

0.95

0.03

1.8

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

906

1.01

0.02

2.2

2.1

u/field

3.2

2.8

0.21

343

(3029075) Extractable nuclear Ab panel - Serum

324

0.98

0.02

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

446

0.98

0.02

2.1

e6/l

477.4

523.8

0.17

378

(3006270) Folate [Moles/volume] in Blood

116

934

1.01

0.01

1.1

1.2

nmol/l

343.4

378.3

1.17

100

792

(3020876) Protein [Mass/time] in 24 hour Urine

602

1.01

0.01

1.6

g/24h

0.3

0.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

143

0.96

0.01

2.5

2.6

u/field

0.4

0.8

1.70

143

(3019174) dRVVT (LA screen)

0.94

0.00

1.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

117

1.04

0.00

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

248

0.98

0.00

2.3

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

248

0.98

0.00

2.3

2.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.95

0.00

1.7

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

245

0.99

0.00

1.4

nmol/l

89.5

131.4

2.06

160

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

182

0.98

0.00

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

220

1.00

0.00

2.7

2.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

273

1.01

0.00

1.4

46.0

40.5

0.33

187

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

180

0.99

0.00

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

224

1.01

0.00

1.1

1.3

mu/l

23.7

57.1

2.40

161

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.90

0.00

1.0

1.2

—

(3010422) Chicken meat IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

0.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.97

0.00

1.2

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.01

0.00

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.92

0.00

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.87

0.00

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.93

0.00

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.99

0.00

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.98

0.00

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERPLUS_EXALLC – Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

GWS hits: 66

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) (C3_BREAST_ERPLUS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints